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SUMMARY 
The yeast-to-hyphal growth switch is one of the most prominent biological 
features and a key virulence trait of the human fungal pathogen Candida albicans. 
This switch can be induced by a range of environmental signals and mediated by 
multiple signaling pathways. Among these pathways, the cAMP/protein kinase A 
(PKA) cascade has proved to be the most critical. In response to hyphal induction, an 
essential cellular process for hyphal growth is the polarization of the actin 
cytoskeleton toward the hyphal tips, responsible for transporting new cell materials to 
the site of cell growth. In spite of the greart importance of the cAMP signaling 
pathway and the actin cytoskeleton for hyphal growth, the molecular links between 
them remain largely unknown. The aim of this study is to test a hypothesis that the 
cyclase-associated protein Cap1, which has the capacity to interact with both actin 
and the adenylyl cyclase Cyr1, may play an important role in linking the actin 
cytoskeleton and the cAMP/PKA pathway.  
In the main body of this thesis, Chapter 3 describes the characterization of 
Cap1 in C. albicans (Ca). I first confirmed that CaCap1 indeed has a role in regulating 
Cyr1 activation and certain aspects of the actin cytoskeleton, consistent with earlier 
studies of its orthologue in Saccharomyces cerevisiae. I later found that in addition to 
the N-terminal part that had previously been shown to bind to and activate Cyr1 in S. 
cerevisiae, the G-actin binding site at the C-terminal end is also required for 
producing the maximal level of cellular cAMP during hyphal growth. Interestingly, 
although the C-terminal part of Cap1 cannot bind to Cyr1, it can activate Cyr1 when 
fused to the C-terminal end of Cyr1.  The results indicate that the N- and C-terminal 
parts of Cap1 activate Cyr1 by different mechanisms. By conducting a series of 
immunoprecipitation experiments using cells expressing various truncated versions of 
- xiii - 
Cap1, I obtained strong evidence that Cyr1, Cap1 and G-actin form a ternary complex 
in which Cap1 acts as a bridge. Based on the results above, I hypothesize that G-actin 
may regulate Cyr1 activity through its interaction with Cap1, thereby providing a 
mechanistic link between the cellular actin status and the cAMP signaling pathway. 
Chapter 4 presents functional studies of Cap1 and actin in regulating the 
adenylyl cyclase activity of Cyr1 both in vitro and in vivo. First, I demonstrated that a 
protein complex containning Cyr1, Cap1 and actin can be purified and is sufficient for 
producing cAMP in vitro under hyphal-inducing conditions. In comparison, the 
complex containing a Cap1 mutant deleted of the G-actin binding site at the C-
terminal end exhibited markedly reduced ability of cAMP synthesis. Consistently, 
cells expressing this Cap1 mutant produced a much delayed and lower peak of cAMP 
in response to hyphal induction as well as defective hyphal morphology. Using the 
purified Cyr1/Cap1/actin complex, I found that the actin depolymerization drugs 
Latrunculin A (LatA) and cytochalasin A (Cyto-A) could also inhibit Cyr1 activity 
and this inhibition depends on the presence of the G-actin binding site of Cap1, 
providing further evidence for a direct role of G-actin in regulating Cyr1 activity. The 
results explain the previous intriguing observation that LatA causes poor response in 
the expression of hypha-specific genes. Coimmunoprecipitation experiments showed 
that the drugs did not cause dissociation of actin from the Cyr1/Cap1/actin complex. 
Thus, I propose that the actin depolymerizing drugs act by causing conformational 
changes of the ternary complex resulting in impaired response to the hyphal-inducing 
signals. Furthermore, the finding that the purified Cyr1/Cap1/actin complex can 
increase cAMP synthesis in response to hyphal-inducing molecules indicates that the 
complex is essentially an intact sensor/effector module for activated cAMP synthesis.  
- xiv - 
In Chapter 5, I propose a model on how Cap1 and actin regulate Cyr1 activity 
during C. albcians hyphal growth. The results of this study for the first time 
demonstrate that G-actin plays an active role in directly regulating cAMP synthesis by 
forming a ternary complex with Cyr1 and Cap1, revealing a mechanistic link for the 
regulation of the cAMP/PKA pathway by the status of the cellular actin cytoskeleton. 
The purified Cyr1/Cap1/actin complex can serve as a useful model for further studies 
of signal sensing and the activation of the cyclase in response to other molecules 
known to cause changes in cellular cAMP levels. 
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CHAPTER 1  
Introduction 
Candida albicans is an opportunistic human fungal pathogen that has received 
an increasing amount of interest in both clinical medicine and fundamental biology.  
Usually, C. albicans is a member of the normal microbial flora colonizing human 
gastrointestinal and vaginal tracts (Odds, 1988). In healthy human hosts, it may only 
cause a range of mild superficial infections (Richardson, 1991). But in 
immunocompromised patients, life-threatening systemic candidiasis may develop 
(Rabkin et al., 2000; Richards et al., 1999). In recent years, candidiasis has become 
more and more severe due to the rapid global spread of AIDS and the wide use of 
powerful antibiotics and immune-suppressive therapies during organ transplant or 
anti-leukemia therapies (Ruhnke, 2004). To make the situation worse, treatment of 
candidiasis is difficult due to the limited choices of anti-C. albicans drugs. 
Furthermore, drug-resistant strains have been found all over the world (Boken et al., 
1993; Odds, 1993; Sanglard et al., 1995). Thus, in order to better control this life-
threatening disease, it is urgent to understand the biological processes of C. albicans 
relevant to infection. 
Besides its medical significance, C. albicans is also an important model for 
studying some fundamental biological issues. Researchers have been aware of its 
dynamic genome as well as its unusual sexual cycle (Hull et al., 2000; Magee and 
Magee, 2000; Perepnikhatka et al., 1999). More importantly, C. albicans has the 
ability to grow in different morphologies such as yeast, hyphae and pseudohyphae 
(polymorphism) in response to different environmental stimuli. All these 
morphologies have importance in virulence, and proper transitions between them have 
been shown to be essential for infection and virulence (Mitchell, 1998). To control 
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these transitions properly, C. albicans uses multiple biological processes, some of 
which are conserved for morphological transitions in higher eukaryotes. Thus, 
elucidating the mechanisms underlying C. albicans morphological transitions will 
undoubtedly contribute to a greater appreciation of fungal pathogenesis and virulence 
as well as the understanding of cell morphogenesis, polarity control and cell-cycle 
regulation. 
To date, several key events of C. albicans morphological transition have been 
discovered, including the phosphorylation of the septin Cdc11 in the early stage of 
hyphal devlopment (Sinha et al., 2007), the transcriptional upregulation of hypha-
specific genes (HSGs) by signaling pathways (Berman and Sudbery, 2002; Bockmuhl 
et al., 2001; Brown and Gow, 1999; Liu, 2001; Sonneborn et al., 2000; Stoldt et al., 
1997; Whiteway and Oberholzer, 2004), and the conserved polarization of the actin 
cytoskeleton and its regulators (Hazan and Liu, 2002; Li et al., 2005). All these events 
have to be precisely coordinated for a successful morphological transition. To achieve 
the coordination, it is important to have regulatory links between different processes. 
However, these links are poorly understood in most cases.  
This study is focused on the identification and characterization of molecular 
links between the cAMP/PKA pathway and the actin cytoskeleton. The thesis will 
describe the study of the cyclase-associated protein Cap1, which had previously been 
shown to interact with both actin and the adenlyly cyclase Cyr1. In the following 
introduction section, I will review the pathogenesis of C. albicans and the response of 
the host defense systems during infection, current understanding of different 
processes of its morphological transition, and previous studies on Cap1. 
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1.1  Pathogenesis of C. albicans  
1.1.1  Candidiasis 
C. albicans and other Candida spp. are frequently isolated from various 
mucosal sites such as gastrointestinal and vulvovaginal tracts, but few cases develop 
into clinical diseases. The integral host tissues and the intact immune system maintain 
a commensal relationship between C. albicans and host (Calderone, 2001). It is 
believed that host environmental changes trigger fungal proliferation and thus lead to 
infection (Edwards, 1996). Clinically, candidiasis can be classified into superficial 
infections and deep infections. Superficial infections include the cutaneous 
candidiasis and two types of mucosal infections: gastrointestinal candidiasis and 
vaginal candidiasis. Deep infections are also called invasive candidiasis, which may 
happen in deep organs or as hematogenously disseminated infections (blood stream 
candidiasis).  
Cutaneous candidiasis occurs on skin or nails. Acute cutaneous candidiasis 
may produce intense erythema, edema, creamy exudates and satellite pustules on the 
skin (Erbagci, 2004). It most frequently occurs in warm, moist conditions such as 
under diapers of newborns, in skin folds and in tropical climates. It is the only type of 
candidiasis that happens in healthy human hosts (Kirkpatrick et al., 1971). 
Patients with impaired epithelial surfaces (trauma burns and even after surgery) 
or reduced resident bacteria (treated with broad-spectrum antibiotics) are inclined to 
get mucosal candidiasis (Rolstad and Erwin-Toth, 2004). In this situation, C. albicans 
is shown to migrate across an intact gastrointestinal or vaginal lumen. The activation 
of phospholipases and proteinases confers C. albicans the ability to adhere and invade 
the damaged epithelial surfaces (Mavor et al., 2005).     
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When C. albicans penetrates the mucosal surfaces and disseminates through 
the circulation system, it causes invasive candidiasis. Risks of this disease include 
extremes of age, immunosuppression (AIDS or cancer patients) (Kasper and Buzoni-
Gatel, 1998), malignancy with leucopenia, major abdominal surgery, trauma, 
exposure to multiple antibacterial agents, central venous catheterization, prolonged 
period of stay in intensive care units, and poor nutrition.  
Invasive candidiasis is life-threatening but its treatment is difficult. C. albicans 
generates strong drug resistances against the traditional antifungal agents such as 
amphorestericin B, azoles and 5-fluorocytosine (St Georgiev, 2000). One possible 
alternative treatment is to improve immunity of the immunocompromised host, 
including the usage of cytokines, chemokines and growth factors. In experimental 
conditions, they are proved to be beneficial. However, in clinical practice, they are 
less effective. It may be due to that an individual alteration is not enough to affect the 
whole immune system. Another alternative treatment is specific immunoprotection. 
Some vaccines are generated, for example antibodies inhibiting morphogenesis of C. 
albicans. However, their clinical values are still under investigation (De Pauw, 2001). 
 
1.1.2 Behaviors of C. albicans during infection 
 Forming biofilms and penetrating cellular surfaces for invasion are two 
important virulence determinants during candidiasis. Both events need the 
polymorphism of C. albicans. Biofilms are defined as “structured microbial 
communities that are attached to a surface and encased in a matrix of exopolymeric 
material” (Ramage et al., 2002). C. albicans biofilms exist on host surfaces of oral 
cavity, esophagus and heart valves. They also exist on implanted biomaterials such as 
pacemakers, stents and catheters. The biofilms cause infections and increase C. 
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albicans resistance to antifungals (d'Enfert, 2006). The formation of biofilms include 
yeast-form cells adhering to a surface by hydrophobic and electrostatic interactions in 
early stages, followed by hyphal formation, expression of adhesin genes and secretion 
of extracellular materials. After 24 to 48 hr of development the fully matured biofilms 
consist of a dense network of yeast cells, hyphae, pseudohyphae and extracellular 
polymeric materials (Hawser and Douglas, 1994). The yeast-to-hyphal transition is 
critical for biofilm formation. Deletion of the transcription factor gene EFG1 or 
CPH1 impairs the formation of filamentous cells and results in rather pool biofilms 
(Lopez-Ribot, 2005). 
Biofilms cause local infections. To cause invasive candidiasis, C. albicans 
cells need to penetrate both mucosal surfaces and blood vessel epithelial cells (Gow et 
al., 2003; Malic et al., 2007). There are two kinds of mechanisms for C. albicans to 
penetrate mucosal surface. One is to generate proteins anchoring to and digesting the 
surface of epithelial cells. For example, Hwp1, a hypha-specific wall protein which 
helps anchoring cells onto the host epithelium (Staab et al., 1999), and SAPs, a group 
of secreted proteolytic enzymes which digest the epithelial surface (Naglik et al., 
2004). Another mechanism is to induce endocytosis of epithelial cells. Being induced 
by C. albicans, epithelial cells produce pseudopods to surround C. albicans cells and 
pull them across epithelial cells to enter blood stream (Rittig et al., 1998). The ability 
of endocytosis induction is related to C. albicans hyphal form: since this ability is 
compromised significantly in cells that fail to form hyphae (Henriques et al., 2007). 
Crossing endothelial cells of blood vessels is similar to the penetration of 
mucosal surfaces, but the endocytosis favorite pathway is different in different 
vascular beds. For example, hyphae are easily taken up by umbical vein endothelial 
cells (Zink et al., 1996), but yeast form cells are easy to be taken into porcine and 
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brain microvascular endothelial cells (Jong et al., 2003). In organs with fenestrated 
blood vessels like kidney, C. albicans can directly pass through between endothelial 
cells. This makes kidney one of the most easily invaded organs by C. albicans 
(Raghavan et al., 1987). Leukocytes can phagocytose C. albicans, but cannot kill it, 
thus make it possible to cross the endothelial cell barrier through the migration of 
leukocytes (Olver et al., 2006). 
Since all these processes are relevant to the polymorphism of C. albicans, 
researches in morphogenesis are important for the eventual control of infections by 
this organism.  
 
1.1.3 Host defense systems 
 The host defense systems against C. albicans can be divided into nonspecific 
and specific immune systems. The former includes the formation of keratinized cells, 
the antifungal lipids from sebaceous glands, and calprotectin (leucocyte protein L1) 
(Brandtzaeg et al., 1995). The latter normally indicates the innate immunity and 
phagocyte-dependent immunity (Mencacci et al., 1999).  
Innate immunity and acquired cell-mediated immunity have been 
acknowledged as the primary mediators of host resistance to C. albicans (Fig 1.1.3). 
The innate immune system discriminates between different forms of the fungus and 
produces sets of cytokines and costimulatory molecules that signal the adaptive T 
helper (Th) immunity. Upon recognition of Candida yeast cells, dendritic cells 1 
(DC1) and polymorphonuclear neutrophils (PMN) produce IL-12 that is required for 
the activation of T help 1 cells (Th1) producing IFN-r and IL-2, which stimulate 
phagocytes to a fungicidal state. In contrast, upon interaction with C. albicans hyphae, 
dendritic cells 2 (DC2) produces IL-4, which is required for the activation of T help 2 
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cells (Th2) producing IL-4 and IL-10, both deactivating phagocytes. Meanwhile, 
production of IL-10 by PMN further contributes to the inhibition of Th1 development. 
This difference shows the importance of hyphae in C. albicans virulence (Romani et 
al., 1997; Wormley et al., 2001) 
 
             
Figure 1.1.3 A simplified view of T helper responses to C. albicans  
 
Cells and their functions involved in the phagocyte-dependent immune 
resistance to C. albicans are (d'Ostiani et al., 2000; Fidel et al., 1993):   
• monocyte/macrophage: phagocytosis, killing, release of chemokines and 
cytokines 
• neutrophil: phagocytosis, killing, release of chemokines and cytokines, 
costimulation 
• endothelial cell: killing, release of chemokines and cytokines 
• dendritic cell: phagocytosis, killing, release of cytokines, antigen presentation 
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• lymphocyte: cytotoxic activity, release of cytokines 
In immunosuppressed patients, the host immune systems cannot protect 
patients from candidiasis. It has been shown that C. albicans could escape from the 
macrophage entrapment by rapid yeast-to-hypha transition (Shin et al., 2005). Now 
Candida spp. rank fourth among microbes most frequently isolated from blood 
cultures of hospitalized patients (Yong et al., 2008). 
  
1.2     Polymorphism of C. albicans 
Polymorphism is important in C albicans invasion of the host. The ability to 
switch between different morphologies is widely accepted to be necessary for 
virulence. An objective measure of C. albicans cell morphology was developed by 
Merson-Davies and Odds (Merson-Davies and Odds, 1989). The measurement is 
based on three cellular dimensions: the length (l), the maximum diameter (d) and the 
diameter at the septal junctions (s). The equation is ls/d2. For ovoid and unicellular 
yeast cells, the index is around 1.0-1.5. For elongated pseudohyphal cells, it is usually 
2.5 to 3.4. In pseudohyphae, the degrees of cell elongation may vary, while the septal 
constrictions are always seen between individual cellular compartments. Hyphae are 
tubular structures without septal constrictions and the cell morphology index is over 
3.4 (Fig 1.2.1). 
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Figure 1.2.1 Different growth forms of C. albicans 
 
Morphological changes between the yeast and the various filamentous forms 
occur in response to alternations in growth conditions. As shown in Fig 1.2.1, a wide 
variety of parameters have been found to affect the morphology of C. albicans 
(Berman and Sudbery, 2002). Some of the parameters reflect host internal body 
conditions, for example, 37°C, serum and HCO3-. In laboratories, the in vivo 
conditions are often mimicked for induction experiments. For example, the 
embedding condition mimics the hypoxia condition, and serum mimics the blood 
stream condition. A combination of conditions may be required to activate hyphal 
development. For example, serum alone is not sufficient to stimulate hyphal 
development if the temperature is below 34oC (Biswas et al., 2007). However, how 
these inducing signals finally lead to the establishment of the polarized growth is still 
under investigation. 
 
1.3    The regulation of morphological transitions 
Several signal transduction pathways are responsible for relaying the hypha-
inducing signals to cellular machineries that execute the morphological switch, such 
as the well-known cAMP/PKA pathway. Downstream of these pathways are the 
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transcription of hypha-specific genes (HSGs), whose functions are highly diverse 
including cell cycle regulation, invasion of substrates and adhesion to host cells. 
Though the yeast-to-hypha switch is cell-cycle independent, inhibition of cell cycle 
progression can induce pseudohyphal growth, which is mediated by distinct signal 
transduction pathway than the hyphal growth. 
    
1.3.1 The cAMP-dependent protein kinase A pathway 
cAMP signaling is involved in many cellular functions including growth, 
metabolism and morphogenesis. In C. albicans, it is considered to be the most 
important signal transduction pathway involved in the yeast-to-hypha growth 
transition. An increase of cytoplasmic cAMP occurs prior to hyphal emergence and 
inhibiting the cAMP generation machine causes defects in almost all hyphal growth 
conditions examined so far (Liu, 2002). 
The core component in this pathway is the cAMP generator: a complex of 
Cyr1 and Cap1. CYR1 (also known as CDC35) is the only adenylyl cyclase gene in C. 
albicans (Mallet et al., 2000). It belongs to the class III adenylyl cyclases. The cyclase 
homology domain (CHD) is located near the C terminus and the catalysis function 
requires Cap1, which will be introduced later in this thesis. Near the protein’s N- 
terminus there is a Ras-association (RA) domain, which is important for Ras1 binding 
and hyphal induction (Fang and Wang, 2006). Cyr1 is activated upon hyphal 
induction. After 30 min of serum induction, the intracellular cAMP level can reach a 
peak level that is ~2-3 fold higher than that in uninduced cells. Deletion of CYR1 
blocks hyphal growth in all conditions tested (Jain et al., 2003).  
Upstream of the core cAMP generator is Ras1, the only Ras homologue in C. 
albicans which is classically considered as an activator of Cyr1. RAS1-deletion strains 
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have severe defects in hyphal growth in response to serum and other hypha-inducing 
conditions. In addition, its dominant negative mutation causes defects in filamentation, 
while its dominant active mutation enhances hyphal formation (Feng et al., 1999). 
Recently, a muramyl dipeptides were found in serum as potent hyphal inducers (Xu et 
al., 2008), it can directly activate cAMP synthesis by binding to the LRR domain of 
Cyr1, suggesting that Ras1 may not be essential for hyphal induction. In some 
conditions, the G protein-coupled receptor Gpr1 and the Gα protein Gpa2 are 
involved in the stimulation of cAMP synthesis, such as intracellular acidification and 
extracellular glucose respectively (Maidan et al., 2005). 
Downstream of the core cAMP generator are two isoforms of PKA catalytic 
subunits Tpk1 and Tpk2. The PKA activity in tpk2 null mutant cells is only 10% of 
that in wild-type cells. This null mutant has severely diminished hyphal growth under 
low serum concentrations (< 5%), while the heat-stable PKA inhibitor (MyrPKI) can 
completely block the yeast-to-hypha transition. These results indicate that both Tpk1 
and Tpk2 are important for hyphal growth (Cloutier et al., 2003). 
One of the most important effectors of Tpk1 and Tpk2 in the yeast-to-hypha 
transition is the transcription factor Efg1, which belongs to APSES proteins 
(transcription factors that mediate fungal morphogenesis) (Borneman et al., 2002). Its 
central helix-loop-helix (bHLH) motif is known to be required for DNA binding and 
dimerization (Bockmuhl et al., 2001). A putative PKA phosphorylation site was found 
at threonine-206, a highly conserved domain of Efg1. Alanine substitution of T206 
leads to a morphogenesis pattern similar to efg1 null mutant (Bockmuhl and Ernst, 
2001). Efg1 is the key regulator in C. albicans morphogenesis: its null mutant blocks 
hyphal formation in a wide range of conditions and overexpression of Efg1 leads to 
strong filamentation in the form of pseudohyphal growth (Stoldt et al., 1997). The 
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group of genes transcriptionally regulated by Efg1 and other transcription regulators 
in the yeast-to-hypha transition are called HSGs, which will be discussed in Chapter 
1.3.3. 
In eukaryotic cells, the intracellular level of cAMP is well controlled. The 
cAMP phosphodiesterase is responsible for the degradation of cAMP (Cantore et al., 
1983). In C. albicans, the high-affinity cAMP phosphodiesterase is called Pde2. 
Deletion of PDE2 causes elevated cAMP levels inhibiting the hyphal growth but 
allowing pseudohyphal growth (Jung and Stateva, 2003). The results suggest that 
hyphal and pseudohyphal growth shares different mechanisms.  
 
1.3.2 Other pathways involved in hyphal growth 
 Besides the cAMP/PKA pathway, several other signal transduction pathways 
are also involved in C. albicans morphogenesis under different induction conditions 
(Fig 1.3.1). For hyphal growth in solid Spider medium (manital instead of glucose 
based medium), the mitogen-activated protein kinase pathway (MAP kinase pathway) 
is required (Navarro-Garcia et al., 1998). This pathway is responsible for 
pseudohyphal growth in S. cerevisiae as well (Levin and Errede, 1995). In C. albicans, 
the components of this pathway are Cek1 (MAP kinase, MAPK) (Csank et al., 1998; 
Whiteway et al., 1992), Hst7 (MAP kinase kinase, MEK) (Clark et al., 1995), Cst20 
(MAP kinase kinase kinase, p21-activated kinase PAK) (Kohler and Fink, 1996), and 
Cph1, the homolog of S. cerevisiae Ste12 (Leberer et al., 1996). CPH1 deletion 
causes defects in hyphal growth and the expression of HSGs. However, gene mutants 
in this pathway exhibit normal hyphal growth in response to serum induction, and 
probably for this reason they also remain virulent in the mouse systemic infection 
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model (Lane et al., 2001b). In addition to morphogenesis, the MAP kinase pathway is 
also required for C. albicans mating system as it is in S. cerevisiae (Chen et al., 2002).  
        
 
Fig 1.3.1 Regulation of polymorphism in C. albicans by multiple signaling 
pathways  
 
For hyphal growth in Lee’s medium (amino acide liquid synthetic medium), 
transcription factor Cph2 is required. It is a β-HLH protein of the myc family (Green 
and Begley, 1992; Steiner et al., 1996). Cph2 binds directly to the sterol-regulatory 
like element in the promoter of another transcription factor Tec1 and Tec2 and 
activates their transcription (Lane et al., 2001b). Tec2 then activates the expression of 
HSGs. Over expression of TEC2 suppresses the hyphal growth defects caused by the 
deletion of CPH2 (Lane et al., 2001a). 
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For hyphal growth in alkaline pH conditions, the most important transcription 
factor is Rim101 (Davis et al., 2000b). As a zinc-finger transcription factor, it 
activates the expression of PHR1 (alkaline-responsive gene) and represses the 
expression of PHR2 (alkaline-repressed gene) (Fonzi, 1999). The activation of 
Rim101 is exerted through proteolytic processing of its C-terminal inhibitory domain. 
Regulated processing of Rim101 requires several RIM family proteins, such as the 
calpain-like protease Rim13/Cpl1 (Blanchin-Roland et al., 2008), the putative 
protease scaffold Rim20 (Davis et al., 2000b), the putative transmembrane proteins 
Rim9 and Rim21/Pal2 , and Rim8/Pal3 of unknown biochemical function (Blanchin-
Roland et al., 2008; Davis, 2003; Davis et al., 2000a; Ramon and Fonzi, 2003). The 
Rim101p-dependent alkaline pH response is not mediated through the repression of 
NRG1 which is a known transcriptional repressor and functions as an inhibitor of 
alkaline pH responses in S. cerevisiae (Lamb and Mitchell, 2003). In C. albicans, 
Nrg1 is responsible for inhibiting hyphal growth in serum and CO2 instead (Moran et 
al., 2007). Besides Rim101, adenylyl cyclase (Cyr1) activity seems to be affected by 
CO2/HCO3-. HCO3- can increase the cAMP level by directly activating Cyr1 catalytic 
domain (Klengel et al., 2005). These data show the importance of the cAMP pathway 
in regulating pH-dependent hyphal growth.  
For hyphal growth in embedding condition (C. albicans cells are embedded in 
agar), the transcription factor Czf1 is required (Brown and Gow, 1999; Whiteway et 
al., 1992). It is a zinc-finger-containing protein, which can activate HSGs expression. 
The expression of CZF1 is dependent on Efg1 and the protein also positively 
autoregulates its own expression (Vinces et al., 2006). 
Besides these positive regulatory pathways, the yeast-to-hypha switch is also 
negatively regulated by Tup1-mediated pathways. The deletion of TUP1 causes 
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constant filamentous growth (Braun and Johnson, 1997). Tup1 acts as part of 
transcriptional repressing complexes through sequence-specific DNA-binding 
subunits.  Two of these DNA-binding proteins are Rfg1 and Nrg1. Rfg1 is a 
homologue of S. cerevisiaes Rox1, a key repressor of hypoxic genes (Sertil et al., 
1997). But in C. albicans it does not contribute to the regulation of hypoxic genes,  
instead it is involved in regulating the expression of HSGs (Kadosh and Johnson, 
2001). Another partner of Tug1 is Nrg1, which is transcriptionally down-regulated 
during hyphal growth (Braun et al., 2001) .  
 
1.3.3 Hypha-specific genes  
 Hyphal growth is associated with the expression of a set of HSGs, whose 
transcripts are induced within a short time after hyphal induction and involved in 
diverse biological functions (Table 1.3.3). A large number of HSGs have been 
discovered and many of them are known or putative virulent factors. However, 
deletion of these genes decreases C. albcians virulence but not impair hyphal growth. 
To date, the only found HSG required for hyphal morphogenesis is HGC1 (Zheng and 
Wang, 2004), which is a G1-cyclin-related gene. The known transcription activators 
that regulate HSGs include Cph1 (MAP kinase pathway), Efg1 (cAMP pathway and 
others), and Czf1 (embedding condition). The negative regulators are Tup1 and its 
associated proteins. The binding sites of these regulators are found in the promoters of 




Table 1.3.3 HSGs are involved in diverse cellular functions (Harcus et al., 2004) 
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Gene name Description 
ALR1 Putative divalent cation transporter 
ARO10 Pyruvate decarboxylase 
CHA2 Catabolic serine/threonine dehydratase 
DDR48 Flocculent specific protein; contains NNDDNSYG motif 
ECE1 Secreted cell elongation protein 
GAP4 Amino acid permease 
HWP1 Hyphal wall protein  
IHD1 Induced in hyphal development; a membrane protein 
IHD2 Induced in hyphal development 
KRE1 GPI-anchored protein for 1,6-β-D-glucan biosynthesis 
PHR1 pH-regulated GPI-anchored membrane protein 
PRY4 Repressed by Tup1  
PTP3 Protein tyrosine phosphatase 
RBT1 A cell wall protein repressed by Tup1  
RBT8 A plasma membrane protein involved in heme-iron utilization 
SAP4 Candida pepsin 4 precursor 
SAP5 Secreted aspartyl proteinase  
SAP6 Candida pepsin 6 precursor 
  
One of the well studied HSGs is HWP1. It encodes a C. albicans cell wall 
protein and is among the best understood proteins involved in Candida adhesion to 
host cells. It is covalently linked to cell wall glucans through its GPI anchor, and its 
N-terminal domain serves as a substrate for mammalian transglutaminases, which 
cross-link Hwp1 covalently to host cell surface proteins (Staab et al., 2004). This 
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protein is essential for the tight adherence to oral epithelial cells (Staab et al., 1999). 
Besides its contribution to virulence, it also contributes to mating, which is required 
for the biofilm formation between mating partners (Nobile et al., 2006). 
  Another group of well-known HSGs and important virulence factors are 
secreted aspartic proteinases (SAP1-10). These extracellular hydrolytic enzymes cause 
host tissue damage and are crucial for C. albicans to break through the host mucosal 
barriers (Naglik et al., 2004). They also contribute to activating host interleukin 1 (IL-
1) and inducing the epithelial cytokine response. Thus, they become useful markers 
in diagnosis of invasive candidiasis (Morrison et al., 2003). The promoters of SAP4-6 
contain repetitive TEA/ATTS consensus sequence motifs, and these genes are 
specially transactivated by Tec1, a member of the TEA/ATTS family of transcription 
factors that regulates C. albicans virulence depending on Efg1 (Schweizer et al., 
2000). 
 HGC1 is the only HSG known to be required for hyphal morphologenesis. It 
encodes a G1-cyclin- related protein, and can co-precipitate with the cyclin-dependent 
kinase Cdc28 (Futcher, 1991). However, HGC1 expression is not cell-cycle 
dependent but is activated by the cAMP pathway and negatively regulated by Tup1. 
Though overexpression of HGC1 alone is not sufficient to induce hyphal growth, the 
deletion of HGC1 abolishes the filamentous growth of TUP1 depletion mutant, as 
well as the actin polarization during hyphal growth (Zheng and Wang, 2004). 
Recently, Hgc1 was found to mediate the hyperphosphorylation of Rga2 by Cdc28  
(Zheng et al., 2007). Rga2 is a GTPase-activating protein (GAP) of the central 
polarity regulator Cdc42. Deletion of RGA2 or inactivation of its GAP activity rescues 
hyphal growth in the hgc1 null mutant, suggesting that Rga2’s GAP activity is 
repressed by Cdc28/Hgc1 during hyphal induction. Cdc28/Hgc1 also prevents Rga2 
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from localizing at the hyphal tips, thus allowing Cdc42 activation for hyphal 
extension (Zheng et al., 2007). Cdc28/Hgc1 is also found to be required for 
maintaining the hypha-specific phosphorylation of the septin protein Cdc11 (Sinha et 
al., 2007). These results demonstrate the importance of Hgc1 in hyphal 
morphogenesis. 
 
1.3.4 Cell cycle inhibition and pseudohyphal growth 
 Although hyphal growth can occur independently of cell cycle phases, 
inhibition of cell-cycle progression can induce pseudohyphal growth. These cell-cycle 
inhibitory conditions include a range of genotoxic insults, such as inhibition of DNA 
synthesis by hydroxyurea (HU) or aphidicolin (AC), depletion of the ribonuceotide 
reductase subunit Rnr2, and DNA damages by methylmethane sulphonate (MMS) and 
ultraviolet (UV) (Whiteway and Bachewich, 2007). Cell-cycle checkpoint pathways 
are involved in this type of filamentous growth. The deletion of RAD53, a 
downstream effecter of the DNA replication/damage checkpoint pathways, abolishes 
this kind of filamentous growth (Shi et al., 2007). Deletion of RAD9, a signal 
transducer of the DNA damage checkpoint blocks the filamentous growth induced by 
MMS and UV but not that by HU and AC (Shi et al., 2007). It seems that DNA 
replication/damage checkpoints are critically required for the genotoxic-stress-
induced filamentous growth. RAD53 mutants carrying certain mutations in its FHA1 
domain can block the filamentous growth without significant deleterious effect on cell 
cycle arrest. The separation by FHA domain mutations of cell cycle arrest and 
filamentous growth suggests the possibility that the later might also be one of the 
Rad53-regulated cellular responses in C. albicans (Shi et al., 2007). 
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1.4 Polarity establishment  
1.4.1 Actin 
 The pattern of C. albicans growth reflects the pattern of actin polarization. In 
small and medium-sized buds of yeast cells, actin cortical patches cluster at the 
growing tip and cables are orientated towards the tip, thus driving the polarized 
growth. However, in large buds, isotropic growth occurs: the patches become 
dispersed over the surface of the buds and cables are no longer orientated towards the 
tip. By contrast, hyphae grow continuously in a polarized fashion and the switch to 
isotropic growth does not occur (Liu, 2001). It has been suggested that actin filaments 
instead of microtubules are essential for C. albicans polarized apical growth, since 
drugs disrupting the actin cytoskeleton inhibit hyphal growth, while drugs that cause 
disassembly of microtubules do not (Yokoyama et al., 1990).  
Unlike in S. cerevisiae where polarized growth is cell-cycle dependent, the 
hyphal growth in C. albicans is cell-cycle independent. Hyphal germ tube can be 
induced at any time of the cell cycle although the cell-cycle progression in yeast and 
hyphae is similar. The hyphal tip-associated polarization of the actin cytoskeleton 
persists, whereas cell cycle-modulated actin assemblies appear and disappear during 
hyphal growth (Hazan and Liu, 2002). The Rho family GTPase Cdc42 and its GDP-
GTP exchange factors are critical for the cytoskeletal changes underlying cell 
polarization processes (Ushinsky et al., 2002). On the other hand, filamentous actin 
(F-actin) is required for the recruitment and maintainance of Cdc42 at the tip of the 
germ tube, which will be described in Chapter 1.4.2. 
The actin cytoskeleton of C. albicans is also composed of cortical actin 
patches and cables. The actin patches are thought to organize endocytosis, whereas 
actin cables direct the transport of secretary vesicles driven by the motor protein 
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Myo2 (Pruyne et al., 2004). Like in S. cerevisiae, during C. albicans polarized growth, 
the actin patches are regulated by the ARP2/3 complex: The Wiskott-Aldrich 
syndrome protein homolog Wal1 has been found in C. albicans. Besides its functions 
in endocytosis and vacuolar morphology, this protein is required for hyphal growth. 
Deletion of this gene causes only pseudohyphal growth under hyphal induction 
(Walther and Wendland, 2004). However, the role of actin patches in hyphal 
establishment and the details of its regulation are still under unclear. On the other 
hand, the actin cables in hyphae are regulated by both polarisome (budding yeast 
pattern) and Spitzenkörper (filamentous fungal pattern). It will be reviewed in 
Chapter 1.4.3.  
      
1.4.2 Rho-GTPase Cdc42 and its regulation  
Cdc42 is a Rho-type GTPase responsible for establishing and maintaining 
polarized growth in many eukaryotic cell types (Brennwald and Rossi, 2007). It also 
has important roles in C. albicans hyphal growth. In Cdc42 functional depletion cells, 
though short germ tubes can be initiated during hyphal induction, the growth cannot 
be maintained (Ushinsky et al., 2002). Hyperactive Cdc42G12V expression under 
hyphal induction results in cells with large, aberrant, branched hyphae-like structure, 
while dominant negative form Cdc42D118A shows typically hyphae with two germ 
tubes and multiple nuclei, suggesting both active GTP-Cdc42 and inactive GDP-
Cdc42 are important for normal hyphal growth. Cdc42 mutants that have defects in 
filamentous growth but retain the normal mitotic functions have been constructed. 
They are Cdcd42S26I, Cdcd42E100G and Cdcd42S158I (VandenBerg et al., 2004). GTP 
binding and hydrolysis are not influenced in these mutants, but they show serious 
defects in hyphal formation in a variety of hyphal-inducing conditions, suggesting 
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mechanisms other than GTP-GDP exchange (Johnson, 1999) are important for C. 
albicans hyphal growth.  
Cdc42 has two types of important regulators: one is guanine-nucleotide-
exchange factor (GEF) which activates Cdc42 by promoting the exchange of bound 
GDP with GTP (Gulli et al., 2000) and the other is GTPase-activating protein (GAP) 
which inhibits Cdc42 by enhancing the hydrolysis of bound GTP to GDP (Lamarche-
Vane and Hall, 1998). In C. albicans, the known GEF of Cdc42 is Cdc24 (Bassilana 
et al., 2005) and the known GAPs are Rga2 and Bem3 (Court and Sudbery, 2007; 
Zheng et al., 2007).  Cdc42 is found to localize at the hyphal tip and so is Cdc24. In 
response to hyphal induction, CDC24 transcript level increases transiently, suggesting 
its importance in hyphal growth (Bassilana et al., 2005). Cells lacking Rga2 and 
Bem3 show hyphal-like structure under pseudohyphal-inducing condition. It is found 
that Rga2 can be activated by Cdc28/Hgc1, suggesting that CDKs control not only 
pseudohyphal growth but also hyphal growth. And the activated Rga2 is prevented 
from localizing to hyphal tips, thereby maintaining localized activation of Cdc42 at 
the tip during hyphal growth (Bassilana et al., 2005; Court and Sudbery, 2007; Hazan 
and Liu, 2002; Zheng et al., 2007).  
The localization of Cdc42 is also affected by F-actin. F-actin depolymerization 
by LatA causes Cdc42 losing its hyphal-tip localization and then blocks hyphal 
growth (Hazan and Liu, 2002). Interestingly, not only LatA, a reduced level of 
cellular Cdc42 can also lower the expression levels of HSGs. In the case of Cdc42 
reduction, the initial mRNA levels of HSGs are not affected, but they cannot be 
maintained with extended inductions (VandenBerg et al., 2004). In Cdc42 point 
mutants which affect hyphal growths, HSGs expression levels are also repressed 
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(Bassilana et al., 2005). These results suggest that F-actin and Cdc42 may play roles 
in the hyphal signal transduction pathways. 
Two effectors of Cdc42 in C. albicans are Cla4 and Cst20. They are both 
members of the Ste20 family of serine/threonine protein kinases (Martin et al., 1995). 
Deletion of CLA4 in C. albicans causes defects in hyphal formation under all 
conditions examined and deletion of Cst20 causes defects on solid Spider medium 
(Leberer et al., 1996; Leberer et al., 1997). However, how these kinases are involved 
in hyphal growth is not elucidated. 
 
1.4.3 Polarisome and Spitzenkörper  
C. albicans exhibits polarized growth forms of both budding yeast and 
filamentous fungi. Budding yeast uses the polarisome to establish polarized growth 
(early stage of budding and pseudohyphae) (Sprague et al., 2004), while filamentous 
fungi use Spitzenkörper (apical body) for true hyphal growth (Grove and Bracker, 
1970). These two mechanisms are both found in C. albicans hyphae.   
Polarisome represents a structure that nucleates actin cables at the tip of S. 
cerevisiae polarity growth. Components of polarisome include Bud6, Spa2 and the 
formins Bni1 and Bnr1. Formins contain multiple domains that control the assembly 
of actin cables and are regulated by Cdc42 (Sagot et al., 2002). In C. albicans, 
CaBni1 has been identified with 35% aa identity to ScBni1. Several important 
functional domains have been recognized; the FH2 domain is the most conserved, 
consistent with the core function of this domain in actin nucleation. CaBni1 exhibits a 
pattern of cell cycle-controlled subcellular localization during yeast growth, whereas 
at least a fraction of the protein exhibits persistent, cell-cycle independent tip 
localization throughout hyphal growth, suggesting that it has a role in cell polarity. 
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Deletion of BNI1 causes abnormal C. albicans yeast growth with round cells, widened 
bud necks and a random budding pattern. During hyphal induction, the mutant shows 
markedly swollen hyphae and a reduced ability to switch from yeast to hyphae. The 
mutant is also defective in spindle and cytoplasmic microtubule orientation and 
positioning. The second formin Bnr1 has also been found in C. albicans. It is 
recruited to hyphal tips like Bni1. The deletion of this gene results in elongated yeast 
cells with cell separation defects, but without interference in the initiation and 
maintenance of polarized hyphal growth. It may have a role in correcting the defect of 
the bni1Δ/bni1Δ mutant during hyphal growth (Li et al., 2005; Martin et al., 2005). 
 The other polarisome components such as Spa2 (a proposed scaffold protein 
interacting with Bni1) (Snyder, 1989) and Bud6 (a bud site selection protein) (Martin 
et al., 2007) have been identified in C. albicans too. Deletion of these genes causes 
similar yeast and hyphal phenotypes as the deletion of BNI1 (Martin et al., 2005). 
Bud6 is found to interact with actin in yeast two-hybrid analysis, suggesting that Bud6 
may be involved in actin cable organization (Song and Kim, 2006). The SPA2 
deletion mutant shows microtubule defects similar to bni1Δ/bni1Δ (Zheng et al., 
2003). 
 Filamentous fungi have different mechanisms for the regulation of polarized 
growth than the budding yeast. Spitzenkörper (apical body) is responsible for the 
polarized growth in these fungi and is located at or just behind the actively growing 
tips (Harris et al., 2005). It is recognized as a dark region in phase-contrast 
microscopy and rich in secretory vesicles. The composition and mechanisms of 
Spitzenkörper is poorly understood. Although only polarisomes are present in C. 
albicans yeast and pseudohyphae, the Spitzenkörper-like structure is found by FM4-
64 staining in C. albicans hyphae. Its localization is distinct from that of the 
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polarisome components Spa2 and Bud6 and that of Cdc42, while Bni1 localizes both 
at polarisome and Spitzenkörper, suggesting that Spitzenkörper may also be 
responsible for actin cable assembly as polarisome. The integrity of Spitzenkörper 
requires polarisome components and is dependent on actin cables. When actin cables 
are destroyed by Cytochalasin A, the Spitzenkörper disappears and the growth mode 
switches from polarized to isotropic. Thus, actin cables play a role in the 
Spitzenkörper-mediated hyphal growth (Crampin et al., 2005). 
  
1.4.4 Early phosphorylation of the septin Cdc11 
Septins are a group of conserved GTP-binding proteins that associate cellular 
membrane with cytoskeleton. They polymerize to form filamentous structures acting 
as diffusion barriers for proteins between different membrane domains and as 
molecular scaffolds for membrane- and cytoskeleton-binding proteins (Spiliotis and 
Nelson, 2006). In C. albicans yeast cells, septins localize as a tight ring at the mother-
bud neck, but in hyphae they localize at the base, tip and the septa of germ tubes 
(Warenda and Konopka, 2002). 
Cdc11 is one of the septin paralogues in C. albicans. It is found to be 
phosphorylated by Cdc28-Ccn1 immediately after hyphal induction (Sinha et al., 
2007). The phosphorylation sites on Cdc11 are Ser394 and Ser395, which are crucial 
for hyphal growth.  At later stages of hyphal growth, Hgc1 replaces Ccn1 and 
performs an essential function to maintain the hypha-specific phosphorylation of 
Cdc11. The initial phosphorylation of Cdc11 happens within 5 min after hyphal 
induction which is earlier than the time required for HSG proteins to reach a sufficient 
level through activation by the MAP kinase and cAMP/PKA pathways. In fact the 
phosphorylation can happen normally when both of the pathways are blocked (Sinha 
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et al., 2007). Although the downstream events of the hypha-specific phosphorylation 
of Cdc11 are still under investigation, this finding suggests existence of alternative 
posttranscriptional or posttranslational pathways for hyphal development. 
Since septins also play a role in polarized growth in higher eukaryotic cells 
such as spine morphogenesis and dendrite development in neurons (Tada et al., 2007), 
it seems that C. albicans may become a useful model for the study of polarity control 
and polarized growth in general. 
 
1.5 Cyclase-associated protein 1 (Cap1) 
 Though in S. cerevisiae, the cyclase-associated protein 1 is also called Srv2, I 
will refer to it as Cap1 in this thesis, following its common acronym in mammalian 
and other species. The acronym Cap1 is also found for Capping Protein 1 and Cbl-
associated Protein 1, which are not the subject of this thesis.  
1.5.1 Evolutionary conservation of CAP proteins 
 The first adenylyl cyclase-associated protein gene CAP1/SRV2 was isolated in 
S. cerevisiae as a suppressor of the activated RAS2Val19 allele (Quinlan et al., 1992). 
Deletion of CAP1 in S. cerevisiae results in defects similar to the inactivation of the 
adenylyl cyclase Cyr1, such as sensitivity to nitrogen deprivation and inability to 
grow on rich media. The deletion strain also shows rounder and larger cells 
suggesting that the CAP protein has cytoskeletal regulation functions (Field et al., 
1990).   
 Following the discovery of Cap1 in budding yeast, CAPs are found in all 
eukaryotic cells that have been examined so far (Hubberstey and Mottillo, 2002). 
However, not all CAPs are associated with adenylyl cyclases. In mammals, there are 
two kinds of CAP proteins, Cap1 and Cap2, although both are homologues of yeast 
Cap1, none of them associates with mammalian adneylyl cyclases (Yu et al., 1994).  
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 Though different in functions, most CAP proteins are highly conserved in 
structure (Fig 1.5.1). The N terminus of Cap1 is responsible for Cyr1 binding in yeast 
species, and the sequence of this domain is highly conserved in higher eukaryotic 
species with yet undefined functions (Amberg et al., 1995; Kawamukai et al., 1991). 
The more conserved C terminus has actin-regulatory functions in all species (Dodatko 
et al., 2004). In the center of the protein are 2 proline-rich domains P1 and P2. The 
former is characterized as a string of proline residues, while the latter contains a SH3-
domain recognizing motif. These two regions are important for Cap1’s actin 
regulatory function (Bertling et al., 2007; Freeman et al., 1996). Hubberstey and 
Mottillo 2002 performed a protein alignment of 14 CAP proteins and found 7 highly 
conserved regions from N terminus to C terminus (Fig 1.5.1) (Hubberstey and 
Mottillo, 2002). Region A is known as RLE motif, which is important for cyclase 
association. Region B and C are also within the cyclase association domain. Region D 
between P1 and P2 is a verprolin homology domain. Region E has two conserved 
cysteine residues. Region F has a potential serine phosphorylation site for unknown 
kinases, and region G has been demonstrated to be essential for actin monomer 
binding. 
 
Fig 1.5.1 Schematic description of Cap1 (C. albicans) functional domains and 
conserved regions.  
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1.5.2 The actin-regulating function of Cap1 
 Although Cap1 was originally hypothesized as an actin monomer sequestering 
protein (Gieselmann and Mann, 1992), it is now a well-established regulator of actin 
dynamics in all eukaryotes examined so far (Hubberstey and Mottillo, 2002). Cap1 
has highly conserved actin monomer-binding capacity and promotes rapid actin 
turnover by competing with cofilin. With the coordination of other proteins, Cap1 
regulates the actin cytoskeleton during cell growth, elongation, development as well 
as vesicle trafficking and endocytosis. 
The actin-regulating function of Cap1 is based on its ability to interact with 
actin. Immunoprecipitation of yeast and mammalian CAPs can pull down actin, 
suggesting that CAPs associate with actin in vivo (Vojtek et al., 1991). The domain 
responsible for binding G-actin (actin monomer) is mapped to the C-terminal half 
with affinity in the range of 0.5 µM and 5 µM in vitro (Freeman et al., 1996; 
Gieselmann and Mann, 1992; Gottwald et al., 1996). In a crystal structure study 
(Dodatko et al., 2004), the C-terminal region of Cap1 is found to have an unusual β-
strand helix which can form a homodimer with an extensive interface for actin 
binding. Since Cap1’s extreme C-terminus was shown to direct the formation of the 
dimer cap (important for the β-helical core), deletion of this region may compromise 
the helical structure and consequently disrupts the actin monomer binding. Actin 
monomer binding studies show that Cap1 binds with strong preference to ADP-G-
actin (Kd 0.02 μM) compared with ATP-G-actin (Kd 1.9 μM) (Bertling et al., 2004; 
Kim et al., 2004). These studies build the structural foundation of Cap1 as a 
regulatory protein of actin monomer. 
Functionally, Cap1 has been found to play roles in actin dynamics by 
recycling ADF/cofilin and actin monomers for new rounds of actin filament 
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depolymerization or polymerization. This function has been proved by biochemical 
studies (Balcer et al., 2003; Moriyama and Yahara, 2002) and supported by actin 
monomer-binding assays in which Cap1 C-terminus was found to compete with 
ADF/cofilin (Bertling et al., 2004). These in vitro studies are supported by in vivo 
findings. In yeast, Cap1 mutants exhibit a reduced rate of actin patch turnover, and 
Cap1 was found to genetically interact with cofilin (Balcer et al., 2003). In 
mammalian fibreblasts, depletion of CAP (Cap1 and Cap2) results in the 
accumulation of ADF/cofilin as abnormal cytoplasmic aggregates and decreased rates 
of both actin filament depolymerization and polymerization (Bertling et al., 2004). 
Plant cells do not have cofilin, and Cap1 has been reported as a cofilin alternative 
responsible for nucleotide exchange from ATP-actin to ADP-actin (Chaudhry et al., 
2007; Deeks et al., 2007). All these data suggest that Cap1 competes with cofilin for 
binding ADP-actin monomers, allowing rapid actin monomer nucleotide exchange 
and consequently supports rapid turnover of filamentous actin.  
 In addition to Cap1’s ADF/cofilin competing activity, Cap1 was recently 
reported to bind profilin (an ATP-actin monomer binding protein) (Qualmann and 
Kessels, 2002) through its P1 domain (Bertling et al., 2007). The existence of profilin, 
Cap1 and ADP-actin ternary complex suggests that Cap1 may serve to reduce the 
distance between profilin and ADP-actin, thus accelerating the nucleotide exchange 
from ADP-actin to ATP-actin (Bertling et al., 2007). 
In addition to its role in regulating G-actin, Cap1 has also been shown to bind 
Abp1, an F-actin binding protein (Olazabal and Machesky, 2001), through the SH3-
binding domain (P2). This interaction leads to indirect interactions between Cap1 and 
F-actin. Thus, Cap1 may be involved in F-actin regulation and thus take part in 
cellular processes such as vesicle trafficking and endocytosis (Freeman et al., 1996).  
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1.5.3 Regulation of adenylyl cyclases by Cap1 in fungi 
Although Cap1 sequence and domain structure are highly conserved in 
eukaryotes, only fungal CAPs have been found to directly interact with adenylyl 
cyclases. Cap1 is a crucial partner of Cyr1 in cAMP production in responding to the 
signal from GTP-Ras (Hubberstey and Mottillo, 2002). 
Structurally, the N-terminal 31 amino acids of Cap1 contains the domain that 
physically and functionally interacts with the C-terminus of Cyr1 in vivo (Amberg et 
al., 1995). But in an in vitro reconstruction of the Cyr1-Cap1 complex, the first 168 
amino acids were found to be required for Cyr1 activation (Kawamukai et al., 1991). 
The difference may reflect discrepancies of various assay systems in the activity of 
proteins. Nonetheless, all the studies agree that Cap1’s N-terminal region is 
responsible for Cyr1 regulation. 
Functionally, Cap1 assists Ras-Cyr1 interaction and therefore activates Cyr1. 
It was suggested that GTP-bound Ras may interact with Cyr1 within the LRR domain 
and then activate Cyr1 for cAMP generation (Kobe and Deisenhofer, 1994). Later 
studies found a 2nd Ras binding domain at the C terminus of Cyr1, which may be 
more important for Cyr1 activation. However, the binding of Ras at this 2nd binding 
site requires association of Cyr1 with Cap1 N terminus (Shima et al., 2000).  
Since Cyr1 does not localize to actin patches as Cap1 does, the dual functions 
of Cap1 in Cyr1 and in actin were thought to be separated. One report showed that 
mutations at Cap1 N-terminus could only affect its Cyr1 regulation but not its actin- 
related functions (Shima et al., 1997), while another study reported that these mutants 
affected the actin patch localization of Cap1 (Bertling et al., 2004). To date, whether 
and how Cap1 coordinates the Cyr1-mediated functions and actin-mediated functions 
remain unclear.  
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In C. albicans, Cap1 is known as a regulator of Cyr1 like in other fungi. CAP1 
deletion inhibits hyphal growth and virulence. Bahn and Sundstrom ((Bahn and 
Sundstrom, 2001) found that CAP1 null mutants show reduced intraculular cAMP 
levels under hyphal induction, and that adding external cAMP can rescue the hyphal 
defects. These results suggest that Cap1’s Cyr1-regulating function is more important 
for hyphal growth than its actin-regulating functions. In fact, Cap1’s role in regulating 
actin has not been studied in C. albicans yet. 
 
1.6 Research objectives 
 Many studies have been done in discovering mechanisms that control C. 
albicans yeast-to-hypha switch. These studies focus on either hyphal signal 
transduction or polarity establishment (regulation of the actin cytoskeleton). However, 
how these two important aspects are physically and functionally linked with each 
other during hyphal switch still remains unclear. Signal transduction pathways are 
known to receive the inducing signals, but little is known on how they relay these 
signals to the polarity machinery. On the other hand, although defects in the polarity 
machinery have been found to negatively regulate the signal transduction pathways, 
resulting in repression of HSGs, the underlying mechanism is also unknown.  
 Evidence in S. cerevisiae shows that changes in actin dynamics may underlie 
the influence of the actin-regulating system on the signaling system: stabilization of 
the actin cytoskeleton caused by the deletion of SLA1 or END3 was found to result in 
hyperactivation of the cAMP/PKA signaling pathway, and this activation can be 
blocked by adding the actin depolymerization drug LatA. Since the C terminus of 
Cap1 is proved to be required for this phenomenon, this protein is thought to be the 
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mediator between actin dynamics and the cAMP/PKA pathway (Gourlay and 
Ayscough, 2006).  
The main purpose of this study is to characterize C. albicans Cap1 and 
determine whether it mediates crosstalks between actin dynamics and the cAMP/PKA 
pathway during hyphal growth. To achieve this, I performed the following 
experiments. I constructed strains expressing various domain-deletion mutants of 
Cap1, conducted immunoprecipitation to map the interactions between Cap1, Cyr1 
and actin, and determined the influences of the various Cap1 mutants on cAMP 
production, HSG expression and hyphal morphogenesis. I also attempted to purify 
Cyr1-containing complexes from the wild-type and the various Cap1 mutant strains to 
perform in vitro assays of cAMP synthesis in response to hyphal induction signals. 
Many of these experiments were also carried out in the presence of drugs that affect 
actin dynamics in order to define the role of actin in regulating Cyr1 activity.  
The results from these studies may unravel mechanisms that can link the 
cellular actin status and the cAMP/PKA pathway during hyphal development, thus 
contributing to a deeper understanding of the C. albicans yeast-to-hypha growth 
switch. Because actin feedback to signaling systems is not a unique phenomenon in C. 
albicans, my results may also shed light on understanding of similar phenomena in 
other organisms.  
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CHAPTER 2 
Materials and Methods 
2.1 Reagents 
 All laboratory chemicals were purchased either from Sigma-Aldrich Co. (St. 
Louis MI, USA) or Bio-Rad Ltd (Hercules, CA, USA). Enzymes were procured from 
New England Biolabs (Boston, MA, USA) and Roche Diagnositics (Mannheim, 
Germany). Antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa 
Cruz, CA, USA). Radioisotopes were purchased from Amersham (Piscataway, NJ, 
USA). Oligonucleotides used in this study were synthesized by 1st Base Ltd 
(Singapore). 
 
2.2 Strains and culture conditions 
C. albicans strains used are listed in Table 2.1. The strains were routinely 
grown in YPD medium (1.0% yeast extract, 2.0% peptone, and 2.0% glucose), GMM 
(1× yeast nitrogen base without amino acids and 2.0% glucose), or GMM medium 
with required amino acids. All strains were grown with shaking at 30°C for 
appropriate times. For hyphal growth in liquid media, yeast cells were inoculated into 
YPD or GMM medium supplemented with 4-20% newborn calf serum and incubated 
at 37°C. Chemicals used for treating the C. albicans cells are listed in Table 2.2. 
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Table 2.1. C. albicans strains used in this study 
 
Strains  Relevant genotype       Source 
 
SC5314   wild type, clinical isolate            (Fonzi and Irwin, 1993)  
BWP17   ura3Δ/ura3Δ his1Δ/his1Δ arg4Δ/arg4Δ                (Enloe et al., 2000)  
CAP-1Δ   Same as BWP17 except CAP1/cap1Δ::ARG4    This study 
CAP-2Δ-1  Same as BWP17 except cap1Δ::ARG4/cap1Δ::HIS1    This study 
CAP-2Δ-2  Same as BWP17 except cap1Δ::ARG4/cap1Δ::hisG    This study 
abp1Δ/Δ  Same as BWP17 except abp1Δ::ARG4/abp1Δ::hisG    This study 
abp1Δ/Δ:CAP1-GFP Same as abp1Δ/Δ except CAP1-GFP URA3     This study 
cyr1Δ/Δ   Same as BWP17 except cyr1Δ::ARG4/cyr1Δ::hisG    This study 
cyr1Δ/Δ:CAP1-GFP Same as cyr1Δ/Δ except CAP1-GFP URA3     This study 
G-CAP-wt  Same as CAP-1Δ except CAP1-GFP URA3     This study 
G-CAP-N  Same as CAP-1Δ except cap1 (1-852nt)-GFP URA3    This study 
G-CAP-C  Same as CAP-2Δ-1 except cap1 (853-1635nt)-GFP URA3   This study 
G-CAP-C26Δ  Same as CAP-1Δ except cap1 (1-1557nt)-GFP URA3   This study 
G-CAP-N30Δ  Same as CAP-2Δ-1 except cap1 (91-1635nt)-GFP URA3   This study 
G-CAP-P1Δ  Same as CAP-2Δ-1 except cap1 (1-959, 995-1563nt)-GFP URA3  This study 
G-CAP-P2Δ  Same as CAP-2Δ-1 except cap1 (1-1120, 1203-1563nt)-GFP URA3  This study 
MG-CAP-wt  Same asG- CAP-wt except HFM-CYR1 HIS1    This study 
MG-CAP-2Δ  Same as CAP-2Δ-2 except HFM-CYR1 HIS1    This study 
MG-CAP-N  Same as G-CAP-N except HFM-CYR1 HIS1     This study 
MG-CAP-C  Same as CAP-2Δ-2 except cap1 (853-1635nt)-GFP URA3, HFM-CYR1 HIS1 This study 
MG-CAP-C26Δ  Same as G-CAP-C26Δ except HFM-CYR1 HIS1    This study 
MG-CAP-N30Δ  Same as CAP-2Δ-2 except cap1 (91-1635nt)-GFP URA, HFM-CYR1 HIS1 This study 
MG-CAP-P1Δ  Same as CAP-2Δ-2 except cap1 (1-959, 995-1563nt)-GFP URA3,  
HFM-CYR1 HIS1       This study 
MG-CAP-P2Δ  Same as CAP-2Δ-2except cap1 (1-1120, 1203-1563nt)-GFP URA3,  
HFM-CYR1 HIS1       This study 
CCC   Same as CAP-2Δ2 except CYR1-cap1-C URA3    This study 





Table 2.2  Drugs used in this study 
  
Drugs   Source Stock    Final concentration 
 
Hydroxyurea  Sigma  1 M in H2O   50 mM in YPD 
Jasplakinolide  Invitrogen 100 µg/ml in DMSO  10 µg/ml in GMM* 
Latrunculin A   Sigma  20 mM in DMSO   50-400 µM in GMM* 
Cytochalasin A   Invitrogen 1 mg/ml in DMSO  2-10 µg/ml in GMM* 
FM 4-64  Invitrogen 16 mM in DMSO   40 µM in GMM* 
Lucifer Yellow   Sigma      1mg/ml 
5-fluoro-acetic acid Sigma      0.1%  
 
* For negative controls, an equal volumn of DMSO without drug was added to the samples. 
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2.3 C. albicans and S. cerevisiae manipulations 
2.3.1 Transformation 
      C. albicans and S. cerevisiae were transformed by heat shock as follows:  
• Grow cells overnight in 10 ml of a proper medium to a density of 2×108 
cells/ml. 
• Spin down cells at 3000× g for 10 min. 
• Resuspend cells at room temperature in 0.9 ml sterile water. Add 0.1 ml of 
10× TE-LiAc (100 mM Tris-HCl, pH8.0, 10 mM EDTA and 1 M LiAc, 
pH7.5). 
• Incubate 100 μl of the cells with 0.1-5 μg linearlized DNA and 0.6 ml of 50% 
PEG 4000 at 30°C for 1 hr. 
• Heat shock cells at 44°C for 15 min. 
• Pellet cells by centrifugation at 3000× g for 10 min and then resuspend them 
in sterile water and plate them on selective media. 
• Incubate the plates at 30°C for 2-3 days. 
 
2.3.2 Preparation of C. albicans genomic DNA 
       Isolation of DNA from C. albicans and S. cerevisiae was done sequentially by 
enzymatic removal of the cell wall, lysis of the spheroplast, precipitation of proteins 
and purification of the DNA. Cells were treared with zymolyse or lyticase (ICN or 
Sigma-Aldrich Co.) to remove the cell wall. 
• Grow cells overnight in 10 ml YPD at 30°C. 
• Spin down cells at 3000× g in an Eppendorf microfuge for 5 min. 
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• Resuspend cells in 0.5 ml of a buffer containing 1 M sorbitol and 0.1 M 
potassium phosphate (pH7.5) and then transfer the cell suspension to a 1.5 ml 
microfuge tube. 
• Add 5 μl of a 15 mg/ml solution of zymolyase, or lyticase and incubate at 
37°C for 60 min. 
• Centrifuge in an Eppendorf microfuge at 11000× g for 5 min. 
• Decant the supernatant and resuspend spheroplasts in 0.5 ml of 50 mM Tris-Cl 
(pH7.4) and 20 mM Na2EDTA. 
• Add 50 μl of 10% SDS, mix well and incubate the mixture at 65°C for 30 min. 
• Add 0.2 ml of 5 M potassium acetate and place the tube on ice for 60 min. 
• Centrifuge in an Eppendorf microfuge at full speed for 10 min. Transfer the 
supernatant to a fresh tube and add one volume of 100% isopropanol at room 
temperature. Mix and allow the mixture to sit for 5 min. Centrifuge briefly. 
Discard supernatant and air-dry the pellet. 
• Resuspend the pellet in 40 μl of TE (pH7.4). Add 1 μl of a 1 mg/ml solution of 
RNase A and incubate at 37°C for 60 min. 
 
2.3.3 Preparation of C. albicans RNA 
Total RNA was isolated for gene expression analysis using RNeasy Plant Mini 
Kit (Qiagen Inc., Germany) according to the manufacturer’s protocol. 
•  Spin down 1×107 cultured cells at 3000× g. Resuspend cells in 500 µl of 
RLC buffer with supplemented β-mercaptoethanol. Add 200 μl of pre-
cooled acid-washed glass beads (400 μm diameter, Sigma-Aldrich Co Inc.). 
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• Break cells in a Beadbeater (BioSpec Products Inc, Bartlesville, OK, USA) 
for three cycles of 2 min-beating at 4°C with 2 min chilling on ice between 
rounds. 
• Transfer the supernatants to RNA shredder (Qiagen Inc., Germany) and 
spin at 14,000 rpm for 2 min at room temperature to obtain cleared lysate.  
• Add 200 µl ethanol (100%) to the cleared lysate and mix immediately by 
pipetting.  
• Apply the sample to an RNeasy mini column and centrifuge for 15 s at 
14,000 rpm. 
• Add 350 µl of Buffer RW1 to the RNeasy column and centrifuge for 15 s 
at 14,000 rpm 
• Add 10 µl of DNase (Qiagen) + 70 µl of RDD buffer into the RNeasy 
column and let it stand for 15 min at room temperature. 
• Add 350 µl of Buffer RW1 to the column and centrifuge for 15 s at 14,000 
rpm. 
• Add 500 µl of Buffer RPE into the column, centrifuge for 15 s at 14,000 
rpm. Repeat this step twice. 
• To elute RNA, transfer the RNeasy column to a new 1.5 ml Eppendorf 
tube. Pipet 30 µl of RNase free water directly onto the silica-gel membrane. 
Let it stand for 2 min, and centrifuge for 1 min at 14,000 rpm. Repeat this 
step twice. 
 
2.3.4 Preparation of C. albicans total cell lysates  
        Cells were spun down by centrifugation at 3000× g for 5 min. The cell pellet 
was resuspended in 300 μl of ice-cold lysis buffer containing 1% Triton X-100, 5% 
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glycerol, 50 mM Hepes (pH 7.4), 150 mM NaCl, 2 µm DTT, and one protease 
inhibitor mixture tablet (Roche Molecular Biochemicals)/25ml. Then, the cell 
suspension was transferred to a 2-ml screw-cap tube. An equal volume of glass beads 
was added, and the cells were broken by using the Mini-Beadbeater (Biospec 
Products, Inc.) at maximum speed for two cycles of 2-min beating, leaving the sample 
on ice for 2 min between rounds. The cell lysate was cleared at the maximum speed in 
an Eppendorf microfuge for 5 min and the supernatant was transferred to a new 1.5 ml 
tube. Protein concentration was determined by the Bradford assay (Bio-Rad).  
 
2.3.5 Yeast two hybrid assay 
To perform yeast two-hybrid assays. One target DNA sequence was fused to 
the HA-tagged Gal4 transcription activation domain in plasmid pGBK-T7, while the 
other target DNA sequence was fused to the Myc-tagged DNA binding domain LexA 
in another plasmid pGAD-T7. Pairwise combinations of the plasmids pGBK and 
pGAD plasmid were transformed into the yeast strain SFY526 (Fang and Wang, 
2006). A ‘bait–prey’ interaction would activate the expression of a β-galactosidase 
reporter gene, and the yeast cell patches were stained for the β-galactosidase activity. 
Western blottings were performed to confirm the expression of the bait and prey 
proteins. 
 
2.4 Gene disruption and expression 
2.4.1 C. albicans gene deletion 
Gene depletion mutants were constructed by sequential deleting the two copies 
of the gene from BWP17 (Enloe et al., 2000). Gene deletion cassettes were 
constructed by flanking a marker gene HIS1, ARG4 or hisG-URA3-hisG with two 
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DNA fragments corresponding to the 5′- and 3′-untranslated regions of the gene to be 
deleted. The two fragments were PCR-amplified from genomic DNA using 
appropriate oligonucleotide primers containing added restriction sites to facilitate 
ligation (Table 2.3). Transformants were selected using proper dropout GMM media. 
And correct deletion was verified by Southern blotting or PCR. For CAP1 deletion, 
the ARG4 marker gene was used to delete the first copy, and the HIS1 marker was 
used to delete the second copy in constructing the strains expressing GFP-tagged 
Cap1, but in the construction of other cap1Δ/cap1Δ mutants the hisG-URA3-hisG 
cassette was used to delete the second copy. In this situation, after selection on 
dropout GMM media, positive cells were spread onto 5-FOA plates to isolate the Ura- 
clones. Thus two selection markers (HIS4 and URA3) were saved for subsequent 
genetic manipulations. 
 
Table 2 .3 Oligonucleotide primers used in this study 
 
No. Primers Sequence        
 
1 CAP-A  5′ ACTGCATCTTTAAGTAAATG 3′ 
2 CAP-B  5′ GTGTGGATCCCCTTGAACATTGAATTGAC 3′ 
3 CAP-C  5′ GTGTGGATCCCTCAAATTGTTGAACATGCT 3′ 
4 CAP-D  5′ CCAAGGCATCGTAAAACT 3′ 
5 ABP-A  5′ AGAGTTTCTGTAAACCGCTTTACT 3′ 
6 ABP-B  5′ AATTGGATCCTGAAATTTTCGGGGAATCC 3′ 
7 ABP-C  5′ AATTGGATCCGCCAGCTTTCAGGGATTAC 3′ 
8 ABP-D  5′ ATGATGTTGCATCATTAGCATTGG 3′ 
9 CYR-A  5′ CATTTTTAATCTAGTGCCGA 3′ 
10 CYR-B  5′ CGGGATCCTTCAAATGGTGGGTAGCTGAG 3′ 
11 CYR-C  5′ CGGGATCCCACCTTCAGCTGAAGCAACAC 3′ 
12 CYR-D  5′ ATTGATTATCCGGATTATCC 3′ 
13 CAP-CF 5′ GTGTAGATCTTCTGACAGAGTTTTAAAAGAAT 3′ 
 
Contitue on next page 
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No. Primers Sequence        
 
Continue from previous page 
 
14 CAP-CR 5′ GCGCCTCGAGTCCAGCATGTTCAACAATTTG 3′ 
15 CAP-CΔR 5′ AATTCTCGAGTTCATAATCATCATTTTCCTTTGGTGC 3′ 
16 CAP-NΔF 5′ AATTACGCGTGACATTACCATTTTCCAAGA 3′ 
17 CAP-NΔR 5′ AATTACGCGTCATATTTTTTGAATTGTCGT 3′ 
18 CAP-NTF 5′ GGCCCTCGAGTATGAGGCATTTGTCGAACAAG 3′ 
19 CAP-NTR 5′ AATTCTCGAGACCAGAAGCAGACGAAGAA 3′ 
20 CAP-CTF 5′ AATTACGCGTGGAGGAGCAGCTCCACCACCA 3′ 
21 CAP-ProR 5′ AATTACGCGTTCCAGCATGTTCAACAATTT 3′  
22 CAP-ProF 5′ GTGTCTCGAGCATCCATGTCCAAGATATGT 3′ 
23 CAP-P1ΔF 5′ AATTCTGCAGCAACGTTTTTTGATGACACTGA 3′ 
24 CAP-P1ΔR 5′ CCTCCTGCAGAACCAGAAGCAGAC 3′ 
25 CAP-P2ΔF 5′ AATTGTCGACTCTAGTTTATCCGGTGGTGT 3′ 
26 CAP-P2ΔR 5′ GTCATCTCAGATTTGTCGACTTT 3′ 
27 GFP-mutF  5′ TGGTATGGATGAATTCTACAAAATCGATTAA 3′ 
28 GFP-mutR  5′ TTAATCGATTTTGTAGAATTCATCCATACCA 3′ 
29 CYR-CF 5′ AATTGGTACCAATGTTGAGTCTTTGATTGATGCCT 3′ 
30 CYR-CR 5′ AATTGTCGACTTAAGTTCATTAACTGTTTTCA 3′ 
31 CAP-CTF1 5′ AATTGTCGACGGAGGAGCAGCTCCACCACCA 3′ 
32 HWP1 RealF 5′ CGGAATCTAGTGCTGTCGTCTCT 3′ 
33 HWP1 RealR 5′ TAGGAGCGACACTTGAGTAATTGG 3′ 
33 ECE1 RealF 5′ TGGAGCTAATGATGACGTTG 3′ 
34 ECE1 RealR  5′ GTTAGAGATAAGTCTTGGAG 3′ 
35 HGC1 RealF 5′ CTAGTTCTACTGGCTCTACT 3′ 
36 HGC1 RealR 5′ GTACTACATGATGAACTTGG 3′ 
37 HYR1 RealF 5′ AACCTCAGTGCTGCATTAGA 3′ 
38 HYR1 RealR 5′ GACATTAAGAGCTAAGACAG 3′ 
39 IDH1 RealF 5′ ACCACTGTTCTAACGCATAC 3′ 
40 IDH1 RealR 5′ CACCAACGTTACAGTAGTAA 3′ 
41 ACT1 RealF 5′ CCAGCTTTCTACGTTTCC 3′ 
42 ACT1 RealR 5′ CTGTAACCACGTTCAGAC 3′ 
43 HGC1F  5′ CATTTCAACAACCAAATCCAACAACAA 3′ 
44 HGC1R 5′ AAGATATTTCCCACCACATCCAT 3′ 
45 HYR1F  5′ TATTCTTGGTACTACTCTTTGTTCC 3′ 
46 HYR1R 5′ CAGCATGAACAATCAAAGACGATT 3′ 
47 IHD1F  5′ ATGAGACCAACTCCATTATTCTT 3′ 
48 IHD1R  5′ CAGAACCAGCAGTATTAGTGTTAA 3′ 
49 ECE1F  5′ GAATTCAACATGAAGAGAGATGTTG 3′ 
50 ECE1R  5′ ATTCAGCTGATCTAGTAATGAGTT G3′ 
51 HWP1F 5′ ACTGCTCAACTTATTGCTATCGC 3′ 
52 HWP1R 5′ AAGATTCAGGTGTAGTTGAAGCAG 3′ 
53 ACT1F  5′ GGTGAAGAAGTTGCTGCTTTAGTT 3′ 
54 ACT1R  5′ CAATGGCAGAAGATTGAGAAGAAG 3′ 
55 CYR6110 F 5′ TTTGTGCATTTGATGGTAAGCATG 3′ 
56 CAP-upA 5′ GCGGAATCACTGTAGACATCA 3′ 
57 HIS-R  5’ CACTGTATCCTCTTCTGTCCCCA 3’ 
58 ARG-R  5’ CTACTCTTGAAAAATCTT 3’ 
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2.4.2 Construction of Cap1 domain-deletion mutants and epitope-tagging of 
proteins 
DNA fragments for constructing CAP-wt, CAP-N, CAP-C, CAP-N30Δ, CAP-
C26Δ, CAP-P1Δ and CAP-P2Δ strains were PCR-amplified by using the following 
pairs of oligonucleotide primers: CAP-CF/CAP-CR, CAP-NTF/CAP-NTR, CAP-
CTF/CAP-CR, CAP-NΔF/CAP-NΔR, CAP-CF/CAP-CΔR, CAP-P1ΔF/CAP-CR and 
CAP-P2ΔF/CAP-CR, respectively (Table 2.3). For CAP-C and CAP-N30Δ strains, 
an additional 1000 nt CAP1 promoter fragment was PCR-amplified by using primers 
CAP-proF/CAP-proR. For CAP-P1Δ strain, the promoter fragment was PCR-
amplified by using CAP-proF/CAP-P1ΔR, while for CAP-P2Δ, it was amplified by 
CAP-proF/CAP-P2ΔR. For the requirement of appropriate restriction sites on the 
plasmid CIp10, the single BglII site on the original plasmid was destroyed by ligating 
this site with a BamH1 site, and then the single KpnI site was mutated to a BglII site. 
This modified CIp10 was used in all the following constructs. For CAP1-wt, CAP-
C26Δ, and CAP-N strains, each of the PCR products was inserted in CIp10 and fused 
in frame with a GFP fragment at the 3′ end. After linearizing the plasmid at a unique 
restriction site within the CAP1 coding sequence, the plasmid was transformed into 
CAP-1Δ, yielding strains expressing GFP-tagged Cap1. For strains CAP-N30Δ, CAP-
C CAP-P1Δ and CAP-P2Δ, the PCR products were inserted into CIp10 with a 
promoter fragment in front and the GFP fragment behind. The GFP fragment used 
carries a mutation that destroyed the BsrGI site without changing the coded amino 
acid. The plasmids were linearlized with BsrGI at a unique site within the promoter 
and transformed into CAP-2Δ1. The MG- series of strains were constructed similarly, 
except that the HFM-Cyr1 (Fang and Wang, 2006) was added to each strain, and for 
those strains using CAP-2Δ1 above, here the CAP-2Δ2 strain was used instead to 
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construct the corresponding strains. For strains CCC and CG, a 3′ fragment of CYR1 
was PCR-amplified using primers CYR-CF and CYR-CR and ligated into CIp10 and 
fused in frame with the CAP1 fragment encoding the C-terminal half of Cap1 or a 
GFP fragment. The plasmid was linearlized at a unique restriction site in the CYR1 
fragment and transformed into CAP-2Δ1 strain. 
 
2.5 DNA work  
2.5.1 Oligonucleotide primers and PCR 
The primers used in this study are shown in Table 2.3. Restriction sites added 
are underlined. Additional residues were added 5′ to the restriction site to facilitate 
complete restriction enzyme cleavage at the ends of PCR products. 
 Primers 1-12 were used for gene deletion of CAP1, ABP1, and CYR1 
respectively. Primers 13-28 were used for the construction of CAP1 truncations and 
mutations. Primers 29-31 were used for Cyr1 tagging and construction of the strain 
CCC. Primers 32-42 were used for real time RT-PCR analysis of the transcripts of 
HSGs. Primers 43-54 were used for normal RT-PCR analysis of HSG expression. 
 
2.5.2 Recombinant DNA methods 
 General recombinant DNA methods were performed essentially as described 
by (Sambrook, 1989). PCR was carried out using high-fidelity DNA polymerase. 
Restriction enzyme digestion was performed using the appropriate buffers supplied by 
the manufacturers. Blunt ending of DNA fragments was carried out using Klenow 
DNA polymerase. Dephosphorylation of cloning vectors was done using calf 
intestinal phosphatase (CIP). T4 DNA ligase was used for ligation of DNA fragments. 
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DNA sequencing was performed with the Sequenase DNA sequencing kit (U.S. 
Biochemical, USA) according to the manufacturer’s instructions. 
 
2.5.3 Transformation of E. coli  
 Electroporation competent E. coli cells were prepared as follows: 
• Inoculate flasks of SOB (without Mg2+) with a 1:1000 dilution of a fresh 
saturated culture of E. coli. 
• Grow the cells with shaking at 200 rpm at 37°C until OD550 = 0.7. 
• Spin down cells at 2000× g for 10 min and keep cells ice-cold throughout 
the procedure. 
• Wash cells by resuspension in a volume of ice-cold 10% sterile glycerol 
equal to that of the original culture. 
• Spin down cells at 2000× g for 10 min. Repeat the wash step twice. 
• Pour off supernatant and resuspend cells using the glycerol solution 
remaining in the centrifuge bottle. 
• Centrifuge at 2200× g for 10 min. 
• Decant supernatant and resuspend cells in 125 μl of ice cold 10% glycerol 
per 100 ml of original culture.  
• Freeze cells in 20 μl aliquots in liquid nitrogen. 
       For transformation, combine 20 μl of the electroporation competent cells with 
1-2 μl of plasmid or ligation mixture in a 0.2 cm electroporation cuvette and leave the 
mixture on ice for 5 min. Electroporation is done using a Gene Pulser (Bio-Rad) with 
settings at 2 KV voltage, 200 Ω resistance and 25 μF capacitance, respectively. 
Following electroporation, cells are resuspended in 1 ml of SOC and grown at 37°C 
for 1 hr. Aliquots of the cells were spread onto agar plates containing the selective 
medium with appropriate antibiotics. 
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2.5.4 Plasmid preparation and analysis 
Small-scale plasmid isolation from E. coli cultures was carried out using the 
QIAprep Miniprep Kit (QIAGEN Inc., Germany) according to the manufacturer’s 
protocol. 
• Spin down cells from a 5 ml overnight culture by centrifugation at full 
speed in an Eppendorf microfuge. Decant the supernatant and resuspend 
the cells thoroughly in 250 μl of Buffer P1 (50 mM Tris-HCl, pH8.0, 10 
mM EDTA, 100 μg/ml RNaseA). Transfer the cell suspension to a new 1.5 
ml microfuge tube. 
• Lyse cells by adding 250 μl of Buffer P2 (200 mM NaOH, 1% SDS). Mix 
gently by reverting the tube several times. 
• Add 350 μl of Neutralization Buffer N3 (3.0 M potassium acetate, pH5.5) 
and mix gently but thoroughly to prevent localized precipitation. 
• Centrifuge at full speed in an Eppendorf microfuge for 10 min to pellet the 
precipitated proteins and genomic DNA. 
• Transfer the supernatant to a QIAprep column and centrifuge at full speed 
for 30-60 s. Discard the flow-through. 
• Wash the column by adding 0.5 ml of Buffer PB and centrifuge at full 
speed for 30-60 s. Discard the flow-through. 
• Wash column with 0.75 ml of Buffer PE and centrifuge for 30-60 s. 
Discard flow-through and centrifuge the column for 1 min to remove the 
residual wash buffer. 
• Place the column in a fresh 1.5 ml tube. Add 50 μl of Buffer EB (10 mM 
Tris-HCl, pH 8.5) to the column; let it stand for 1 min before 
centrifugation to elute the DNA. 
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Restriction digestions were performed to analyze plasmids. Normally, 1-2 μg 
of the plasmid DNA was digested with 1-2 units of the appropriate enzymes in a 20 μl 
reaction at 37°C for 2 hr. The digestion products were analyzed by agarose gel 
electrophoresis. 
 
2.5.5 Preparation of DNA probes 
 The DNA probes for Southern and Northern blot analysis were prepared using 
the Random Primed DNA Labeling Kit (Roche Diagnostics). A mixture of all 
possible hexadeoxyribonucleotides was hybridized to the template DNA probe as 
primers for DNA synthesis. Complementary strands are synthesized from 3′-OH 
terminus of the hexamers using Klenow enzyme in the presence of dNTPs. Usually, 
dCTP or dATP is 32P-labeled.  
• Take 25 ng of template DNA in 9 μl of H2O. Heat-denature the DNA at 
95°C for 10 min followed by chilling on ice.  
• Add 1 μl each of dATP, dGTP, and dTTP and 2 μl of 10× reaction buffer 
containing the hexadeoxyribonucleotide mixture. 
• Add 5 μl of [α-32P] dCTP, (3000 Ci/mmol) 
• Add 1 μl of Klenow enzyme (1 U/μl) and incubate the reaction at 37°C for 
30 min. 
• Remove unincorporated dNTPs by chromatography on a TE-10 chroma-
spin column (Clontech Inc., La Jolla, CA, USA) by following the 
supplier’s procedure. 
• Heat-denature the 32P-labeled DNA at 95°C for 10 min, chill on ice and 
add to the hybridization mixture. 
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2.6 RNA work 
2.6.1 RT-PCR 
The Reverse Transcription System (Promega Co. Madison, WI USA) is used 
to obtain the first-strand DNA by following the manufacturer’s protocol. 
• Place a 1 µg aliquot of the target total RNA sample in a microcentrifuge 
tube and add RNase free H2O to 10 µl, incubate the sample at 70°C for 10 
min, and spin briefly in a microcentrifuge, and then place the sample on 
ice. 
• Prepare a 10 µl reaction mix by adding 5 mM MgCl2, 1× reverse 
transcription buffer (10 mM Tris-HCl [pH 9.0 at 25°C], 50 mM KCl, 0.1% 
Triton® X-100), 1 mM each dNTP, 0.5 U recombinant RNasin® 
ribonuclease inhibitor, 15 U AMV reverse transcriptase (High Conc.), 0.5 
µg Oligo(dT). 
• Mix the reaction mix to the RNA sample gently and incubate the reaction 
at 42°C for 1 hr, followed by heating at 95°C for 5 min and keeping the 
sample at 4°C for another 5 min.  
One microliter of the first-strand cDNA is used for a 25-µl PCR reaction, and 
the cycle number is 25. 
 
2.6.2 Real time RT-PCR 
 Real time RT-RCR was carried out using LightCycler 2.0 system (Roche). It is 
used to perform one-step RT-PCR in 20 µl glass capillaries. The amplicon is detected 
by measurement of the SYBR Green I fluorescence signal. The signal (wavelength 
530 nm) is emitted only when the the SYBR Green I molecules are intercalated into 
the DNA double helix. Therefore, during PCR, the increase in SYBR Green I 
fluorescence is directly proportional to the amount of double-stranded DNA generated. 
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• 5 µl total RNA (2 ng in this study) was mixed with 1× reaction mix, 1× 
resolution solution, 6 mM MgCl2, 5 mM primer mix, 1× enzyme mix to a 
final volume of 10 µl. Mix gently, and pipet the mix into the lightCycler 
Capillary. 
• After a brief spin, transfer the capillaries into the LightCycler sample 
carousel, and cycle the sample strictly following the ‘LightCycler 2.0 
System Protocol’.  
• The results were analyzed by lightCycler Software Version 4.0 
 
2.7 Protein work 
2.7.1 Western blot analysis 
SDS-PAGE was carried out as described in standard protocols (Sambrook et 
al., 1989) using the Mini-PROTEAN II electrophoresis system (Bio-Rad, USA) in 
Tris-glycine buffer (25 mM Tris, 250 mM glycine, and 0.1% SDS). The proteins 
resolved on SDS-PAGE were then transferred onto PVDF membrane (Amersham, 
UK) using either the Transblot semi-dry transfer cell (Bio-Rad) or the Bio-Rad Wet 
Transfer System in transfer buffer (48 mM Tris, 39 mM glycine, and 10% methanol). 
The membrane was then incubated for 60 min in blocking buffer (PBS containing 5% 
non-fat milk) at room temperature. The membrane was then incubated with the 
primary antibody in PBST (PBS with 0.05% Tween-20) containing 1% non-fat milk 
for 90 min at room temperature and washed extensively in PBST buffer. The 
membrane was then incubated in PBST containing 1% non-fat milk and the 
horseradish peroxidase-conjugated secondary antibody for 60 min at room 
temperature. The membrane was then extensively washed in PBST. Antibody-antigen 
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complexes were visualized by using the Enhanced Chemi-Luminescence (ECL) 
system (Amersham, UK). 
 
2.7.2 Immunoprecipitation (IP) 
 An equal volume of a cell lysate was mixed with either anti-Myc, anti-actin or 
anti-GFP agarose beads (Santa Cruz, CA, USA) and rotated for 2 hr at 4°C. Then the 
beads were washed with lysis buffer 3 times and spun down. The precipitated proteins 
were then resolved by SDS-PAGE as described in 2.7.1. The precipitated proteins 
were detected by Western blotting. 
 
2.7.3 Expression and purification of GST-fusion proteins 
The different regions of CAP1 were cloned into the pGEX-4T-1 expression 
vector (Amersham Pharmacia Biotech) in frame with the glutathione S-transferase 
sequence. The construct was transformed into the E. coli strain BL21 (Amersham 
Pharmacia Biotech). Purification of GST-fusion proteins was performed as described 
previously (Frangioni and Neel, 1993). One liter of bacterial culture was grown to 
OD600 = 0.8-1.0 before a 6-hr induction with 1 mM IPTG at 30°C. Cells were pelleted 
and resuspended in 40 ml lysis buffer (10 mM Tris-HCl, pH 8.0, 1 mM DTT, 1 mM 
EDTA, 150 mM NaCl, 0.5% Triton X-100, and one protease inhibitor mixture tablet 
[Roche Molecular Biochemicals]). Lysis was performed by 8 rounds of 1-min 
sonication at 4°C with cooling of the sample on ice between rounds. The lysates were 
cleared by centrifugation, mixed with 1 ml glutathione Sepharose 4B beads 
(Amersham Biosciences) and incubated at 4°C for 3 hr. The beads with bound 
proteins were washed twice with 10 ml of lysis buffer and twice with 10 ml of F-
buffer (10 mM Tris, pH 7.5, 0.2 mM CaCl2, 0.5 mM DTT, 0.2 mM ADP or ATP, 1 
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mM MgCl2, 100 mM KCl). To quantitate the protein on beads, aliquots of the sample 
were resolved by SDS-PAGE together with known amounts of a standard protein. 
After Coomassie blue staining of the gel, the amount of the sample protein was 
compared visually with the standard protein. 
 
2.7.4 Actin depletion pull-down assay 
First, ATP- and ADP-actin were prepared from the rabbit skeletal muscle 
monomeric actin (Sigma).   
• Dissolve the actin powder in F-Buffer with ATP (Sigma) and then remove 
actin filaments by ultracentrifugation at 65,000× g for 2 hr. 
• Devide the ATP-actin solution into small aliquot and rapidly freeze them at 
minus 20°C. Prior to use, the ATP-actin solution is quickly thawed in a 37°C 
water bath. 
• ADP-actin is prepared from the ATP-actin solution by adding 2 mM ADP 
(Sigma), 20 U/ml hexokinase (Sigma) and 1 mM glucose followed by rotary 
incubation at 4°C overnight. 
To perform the actin depletion pull down assay, 250 µl of 3 µM ADP-actin or 
2.3 µM ATP-actin was incubated alone or with 9 µM GST-Cap1 fragments coupled to 
beads for 15 min at room temperature. The samples were centrifuged for 5 min at 
13,000× g to pellet the beads and bound proteins. The amount of actin present in the 
supernatant was then examined on Coomassie-stained 12% SDS gels. In this study, 




Chapter2  Materials and Methods 
 49
2.8 Microscopy and fluorescence studies  
2.8.1 Microscopy 
I used a Leica DMR fluorescence microscope with a 100× objective lens and a 
Hamamatsu digital camera interfaced with METAMORPH software (Universal 
Imaging). Cell morphology was examined by using differential interference contrast 
optics (DIC) for morphological analysis. GFP and rhodamine were visualized by 
using corresponding fluorescence settings. For morphology and GFP localization, 
living cells were examined immediately without fixing. Nuclei were stained directly 
by using the Vectorshield mounting medium containing DAPI (Vector laboratories, 
Burlingame, CA, USA).  
 
2.8.2 Endocytosis assays 
In this study, two kinds of endocytosis assays were used. The Lucifer yellow 
(LY)  assay was carried out for detecting the endocytic ability of the cells, while FM 
4-64 staining was used for observing the dynamic process of endocytosis. 
In the LY assay, LY dilithium salt (Sigma) was added to the log-phase yeast 
cells to a final concentration of 1 mg/ml. After a  2-hr incubation, cells were washed 3 
times with PBS containing 10 mM sodium azide and then 3 times with PBS, and were 
observed under Leica DMR fluorescence microscope using FITC channel. 
For FM 4-64 staining, FM4-64 (Molecular Probes, Eugene, OR, USA) was 
added to the cell culture with OD600 0.8-1.6 to the final concentration of 40 µM. The 
cells were immediately observed using the rhodamine channel and photos were taken 
every 10 min. 
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2.8.3 Actin staining by rhodamine-phalloidin  
• Spin down 100-200 µl of log-phase cells in a 1.5 ml Eppendorf tube. 
• Fix cells with 4% formaldehyde (Sigma) in Kphos Buffer pH 6.4 (80 
mM KH2PO4 and 20 mM K2HPO4) at room temperature for 1 hr or at 
4°C overnight. 
• Wash cells twice with Kphos Buffer pH 6.4 
• Stain cells with rhodamine-phalloidin for 1.5-2 hr at room temperature 
(avoid light) 
• Wash cells with PBS 5 times 
• Spin down and resuspend cells in 10 µl of DAPI mounting solution  
• Use 1 µl of cells for fluorescence microscopy and save the rest of the 
sample at -20°C  
 
2.9 Cyclase activity and cAMP assays 
2.9.1 cAMP assay in vivo 
• Cells were grown to mid-log phase in GMM at 30°C 
• Harvest cells and inoculate them into Hank’s balanced salt solution 
(HBSS, pH7.5) containing 20% serum and incubate at 37oC for hyphal 
induction 
• Harvest cells at timed intervals by centrifugation and quickly freeze 
cell pellets in liquid nitrogen. 
• After samples of all time points are collected, thaw cells on ice and 
resupend them in H2O. 
• Save half of each sample and freeze it on dry ice for freeze-drying 
overnight. The weight of the dried cell pellet is then measured.  
Chapter2  Materials and Methods 
 51
• Transfer the other half of the sample to a 2-ml screw-capped centrifuge 
tube. Add 10% TCA 500 ul to the cell pellet and lyse the cells by bead-
beating as described in Chapter 2.3.3 
• Neutralize the cell lysate in water-satuated ether (500 µl each time) for 
5 times to get rid of TCA, and freeze-dry the sample overnight. 
Then the amount of cAMP in the sample was determined using Amersham’s 
cAMP Biotrak Enzymeimmunoassay (EIA) system. The following protocol is 
according to the manufacturer’s instruction. 
Assay buffer: Transfer the contents of the bottle to a 500 ml graduated 
cylinder by repeated washing with distilled water. Adjust the final volume to 
500 ml with distilled water and mix thoroughly. The diluted buffer contains 
0.05 M acetate buffer pH5.8 containing 0.02% (w/v) bovine serum albumin, 
and 0.01% (w/v) preservative. 
Standard: Carefully add 2.0 ml of diluted assay buffer and mix the contents 
of the bottle until completely dissolved. The final solution should contain 
cAMP at a concentration of 32 pmol/ml in 0.05 M acetate buffer containing 
0.02% (w/v) bovine serum albumin and 0.01% (w/v) preservative. 
Antiserum: Carefully add 11 ml diluted assay buffer and gently mix the 
contents of the bottle by inversion and swirling until a complete solution is 
obtained. Vigorous agitation and foaming should be avoided. An aliquot of the 
antiserum should be diluted with an equal volume of assay buffer prior to use. 
The contents will contain anti-cAMP serum in 0.05 M acetate buffer 
containing 0.02% (w/v) bovine serum albumin and 0.01% (w/v) preservative. 
cAMP peroxidase conjugate: Carefully add 11 ml diluted assay buffer and 
mix until the contents are completely dissolved. The solution will contain 
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cAMP-horseradish peroxidase in 0.05 M acetate buffer pH 5.8, 0.02% (w/v) 
bovine serum albumin and 0.01% (w/v) 
Wash buffer: Transfer the contents of the bottle to a 500 ml graduated 
cylinder by repeated washings with distilled water. Adjust the final volume to 
500 ml with distilled water and mix thoroughly. The diluted wash buffer 
contains 0.01 M phosphate buffer pH 7.5 containing 0.05% (v/v) Tween 20. 
• Working standards preparation 
o Label 8 polypropylene or polystyrene tubes (12 x 75 mm), 12.5 
fmol, 25 fmol, 50 fmol, 100 fmol, 200 fmol, 400 fmol, 800 fmol 
and 1600 fmol 
o Pipette 500 μl diluted assay buffer into these tubes 
o Into the 1600 fmol tube pipette 500 μl of stock non-acetylation 
standard (32 pmol/ml) and mix thoroughly 
o Transfer 500 μl from the 1600 fmol tube to the 800 fmol tube and 
vortex mix thoroughly 
o Repeat this doubling dilution successively with the remaining tubes 
and vortex after each dilution 
o 100 μl aliquots from each of the serial dilutions will give rise to 8 
standard levels of cAMP from 12.5-1600 fmol 
• Assay method  
o Prepare assay components and standards ranging from 12.5-3200 
fmol as described in the previous sections 
o Equilibrate reagents to room temperature and mix before use 
o Set up the microplate with sufficient wells for running of all blanks, 
standards and samples. Recommended positioning of blank (B), 
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non-specific binding (NSB) wells, standard (0-3200 fmol) and 
sample (S) 
o Pipette 200 μl of diluted assay buffer into the non-specific binding 
(NSB) wells 
o Pipette 100 μl of diluted assay buffer into the zero standard wells 
(0) 
o Pipette 100 μl of each standard into the appropriate wells, using a 
clean pipette tip for each standard 
o Pipette 100 μl of unknown sample into the appropriate wells 
o Pipette 100 μl of antiserum into all wells except the blank and NSB 
wells 
o Cover the plate with the lid provided and gently mix and incubate 
at 3–5°C for exactly 2 hr 
o Carefully pipette 50 μl cAMP–peroxidase conjugate into all wells 
except the blank 
o Cover the plate, gently mix and incubate at 3–5°C for exactly 60 
minutes 
o Aspirate and wash all wells 4 times with 400 μl wash buffer. Blot 
the plate on tissue paper ensuring any residual volume is removed 
during the blotting procedure 
o Immediately dispense 150 μl enzyme substrates into each well and 
cover the plate and mix on a microplate shaker for exactly 60 
minutes at room temperature (15–30°C)  
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o Pipette 100 μl 1.0 M sulfuric acid into each well, mix the contents 
of the plate and determine the optical density in a plate reader at 
450 nm within 30 min 
 
2.9.2 Cyclase activity assay in vitro  
 This method was essentially described by Miguel, et al, 2003 and Salomon, et 
al., 1974.  
• Cell lysates are prepared in lysis buffer containing 25 mM Hepes pH 7.3, 
150 mM NaCl, 0.5% Triton X-100, 3% Glycerol and one protease 
inhibitor mixture tablet per 25 ml (Roche Molecular Biochemicals). 
Bradford assay is used to determine the protein concentration.  
• If proteins need to be pulled down using beads, follow the protocol in 
Chapter 2.7.2 
• The cell lysates or the beads with bound proteins are mixed 1:1 with 
reaction buffer (25 mM Hepes pH 7.3, 10 mM MgCl2, 40 mM creatine 
phosphate, 200 U/ml creatine phosphokinase, 2 mM cyclic AMP 2 mM 
[α-32P]ATP, and protease inhibitor mixture tablet per 25 ml 
• The reaction time is 30 min in room temperature. The reaction is stopped 
by adding the same volume of 2% SDS. Control is prepared by stopping 
the reaction at 0 time point. 
• The 50W-X8 Resin (200-400 mesh) (BIO-RAD Laboratories) columns 
are equilibrated by 10 ml H2O each. The samples are added into the 
columns and washed with 4 ml H2O, and then eluted with 20 ml H2O. 
• Aluminium oxide columns with 1-ml bed volume are prepared with 25 
mM Hepes pH 7.3 and equilibrated with 10 ml H2O. The eluted samples 
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from the above step are then loaded into these columns, and eluted with 
10 ml 600 mM imidazole. 
• The 1-X8 Resin (200-400 mesh) (BIO-RAD Laboratories) columns are 
equilibrated by 10 ml H2O each. The eluted samples from above step are 
loaded into these columns, and washed with 3.16 mM HCl, and then 
finally eluted with 4 ml HCl. 
• The produced [32P]-cAMP is quantitated by scintillation counting. 
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CHAPTER 3  
Characterization of C. albicans Cap1 and Its Function in 
Morphogenesis 
3.1 Introduction 
 Recent observations that cellular actin status can influence cAMP signaling in 
both C. albicans and S. cerevisiae emphasize the necessity of further mechanistic 
understanding of CAP’s functions. Because of the essential roles of both actin and 
cAMP in C. albicans hyphal development, this organism can serve as a useful model 
for investigating how CAP links cAMP signaling and actin. Although Cap1’s 
essentiality for hyphal growth has been established (Bahn and Sundstrom, 2001), 
most of its cellular, structural and functional aspects relevant to interactions with the 
actin cytoskeleton has not be characterized. Thus, I felt that it was necessary to start 
with some basic characterizations to determine which functions are conserved and 
which ones might be unique to C. albcians. And then, its role in morphogenesis was 
investigated by using strains expressing mutant versions of Cap1 deleted of different 
functional domains. 
 
3.2 Expressing Cap1 mutants in C. albicans 
 All the strains used in this study are described in Table 2.1 (in Chapter 2). 
To investigate Cap1’s cellular functions in C. albicans, I first constructed 
cap1Δ/Δ mutants. For different purposes, two strains of cap1Δ/Δ mutant (strain CAP-
2Δ-1 and CAP-2Δ-2) were contructed using different gene-deletion cassettes. Strain 
CAP-2Δ-1 was constructed by using the selectable markers ARG4 and HIS1 to 
sequentially replace the first and second copy of CAP1 from strain BWP17 to obtain 
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strains CAP1/cap1Δ::ARG4 (strain CAP-1Δ) and cap1Δ::ARG4/cap1Δ::HIS1 (Fig. 
3.2.1A). And strain CAP-2Δ-2 was obtained by using cassettes ARG4 and hisG-
URA3-hisG (hGh) to finally yield strain cap1Δ::ARG4/cap1Δ::hisG (Fig 3.2.1A). The 
latter construct saves two selectable markers (HIS1 and URA3) for further genetic 
manipulations such as deletion of additional genes or chromosomal tagging of 
proteins, while the former saves only one (URA3). CAP-2Δ-1 and CAP-2Δ-2 were 
verified by PCR analysis of the genomic DNA (Fig 3.2.1B). Using these two null 
mutants, a series of strains expressing CAP1 domain-deletion mutants tagged with 
GFP at their 3′ ends were made (Fig 3.2.1C) by site-specific integration at the CAP1 
promoter region in both CAP-2Δ-1 and CAP-2Δ-2 (Fig 3.2.1D), except for strains 
CAP-wt (wild-type), CAP-N and CAP-C26Δ, which were made by integrating the 
mutant construct at a specific site within the wild-type copy of CAP1 in strain CAP-
1Δ (CAP1/cap1Δ::ARG4 ) (Fig 3.2.1E). In each of the mutants constructed using 
CAP-2Δ-2 and CAP-1Δ, one copy of the CYR1 gene was tagged with a HFM tag 
(6His-Flag-6Myc) (Sinha, et al., 2007) at the N-terminus and placed under the control 
of the MET3 promoter (Fang and Wang, 2006) (Fig 3.2.1F). The genotypes of these 
mutants were verified by PCR analysis of genomic DNA, and the expression of Cap1 
and Cyr1 proteins were confirmed by Western blot analysis (Fig 3.3.2E). The 
nomenclatures of these strains are described in Table 2.1: The set of mutants without 
HFM-Cyr1 were designated with the prefix “G-CAP-”, in which G represents GFP. 
This set was mainly used for studying Cap1’s role in actin regulation.  The other set 
with HFM-Cyr1 was designated with the prefix “MG-CAP-”, in which MG represents 
Myc and GFP. This set was mainly used for the study of protein interactions and 
cAMP synthesis. For the convenience of reading, both sets will be generally described 
as “CAP-” in the following sections.    
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Fig 3.2.1 Chromosomal deletion of CAP1 
(A) A schematic description of the strategy for knocking-out (KO) the first and 
second copies of CAP1. The first base of the start codon ATG is designated as 
nucleotide (nt) 1. (B) Verification of CAP1 deletion by genomic DNA PCR. Lane 1, 
SC5314 (wild type); lane 2, strain CAP-2Δ-1; lane 3, strain CAP-2Δ-2. ORF indicates 
amplification of the CAP1 coding sequence by the primer pair CAP-upA/CAP- P2ΔR; 
ARG indicates amplification of the selection marker gene ARG4 that has correctly 
replaced the CAP1 sequence by using the primer pair CAP-upA/ARG-R; HIS 
indicates amplification of the selection marker gene HIS1 that has correctly replaced 
the CAP1 sequence by using the primer pair CAP-upA/HIS-R; and HisG indicates the 
amplification of the hisG sequence that has correctly replaced the CAP1 sequence by 
using the primer pair CAP-upA/HisG-R. All the primers are described in Table 2.3. 
(C) A schematic description of the strategy for constructing Cap1 mutants. The 
restriction sites for linearization (Kpn I, Bam H1 and Bsr GI) are also shown. (D) 
Strategy for re-introducing CAP-N30Δ,  CAP-C, CAP-P1Δ and CAP-P2Δ. (E) 
Strategy for reintroducing CAP-wt, CAP-N and CAP-C26Δ. (F) Strategy for tagging 
CDC35 (CYR1) (Fang and Wang., 2006) 
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Description of Cap1 domain-deletion mutants used in this study  
The Cap1 functional domains are described in Figure 1.5.1. 
z CAP-N: the N-terminal 284 amino acids (aa 1-284). This region contains the 
intact Cyr1 binding domain. 
z CAP-C: the C-terminal part from aa 285 to 545. This region contains P1, P2 and 
the C-terminal G-actin binding site and thus has the potential to interact with both 
F-actin and G-actin. 
z CAP-C26Δ: the C-terminal 26 amino acids (520-545) were deleted. The deleted 
sequence is: ELAVPEQFVSKVVNGKLVTQIVEHAG. This sequence is 
essential for G-actin binding. 
z CAP-N30Δ: the N-terminal region from aa 2-30 was deleted. The deleted 
sequence is: STEESQFNVQGYNIITILKRLEAATSRLE. This sequence is 
essential for Cyr1 interaction and the RLE motifs are conserved in all eukaryotes. 
z CAP-P1Δ: the prolin-rich 1 (P1) domain was deleted. The deleted sequence is: 
GGAAPPPPPPPPP (aa 285-297). This sequence may be involved in the binding 
of profilin, an ATP-actin monomer regulation protein and the formation of Cap1 
homodimer. 
z CAP-P2Δ: the prolin-rich 2 (P2) domain was deleted. The deleted sequence is 
KSEMTHKNPELRKQPPVAPKKPAPPKKP (aa 340-367), including the P2 
domains (PKKP) and a short conserved sequence in front of it. The sequence is 
considered as a SH3 binding domain, which binds the actin-patch-associated 
protein Abp1, consequently locating Cap1 protein to actin patches. 
 
3.3 Interaction of Cap1 with actin and Cyr1 
3.3.1 The C-terminal part of Cap1 binds ADP-G-actin in vitro. 
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 To map the domains of Cap1 responsible for binding G-actin monomers, actin 
depletion assays were conducted. Cap1-N (aa 1-284) and Cap-C (aa 285-545) were 
expressed as GST-fusion proteins in E. coli. Since Cap1’s extreme C-terminus is most 
critical for actin binding (Dodatko et al., 2004), the 26 aa at C-terminus were deleted 
in GST-Cap1-C to obtain Cap1-C26Δ (aa 285-519). This deleted region contains 4 
highly conserved residues corresponding to Cap1’s Glu520, Pro524, Glu525 and Gln527, 
which were thought to be required for G-actin binding (Hubberstey and Mottillo, 
2002), an idea that had not been tested experimentally. The corresponding N- and C-
terminal parts of S. cerevisiae Srv2 were similarly expressed and used as positive and 
negative controls (Bertling et al., 2004). The GST-fusion proteins were purified to 
high homogeneity (Fig 3.3.1) and the same amount of each was bound to a fixed 
quantity of glutathione-Sepharose beads.  The beads were then used to deplete ADP-
G-actin from solution. After spinning down the beads with bound actin, the unbound 
actin molecules were quantified by Western blotting using an actin antibody (clone 
C4 from Santa Cruz, CA, USA). (The preparation of ADP-actin is described in 
Chapter 2.7.4.). The result in Fig 3.3.1 shows that significantly more unbound actin 
molecules were detected after depletion with Cap1-N or Srv2-N than with Cap1-C or 
Srv2-C, indicating that the C-terminal part binds ADP-G-actin more efficiently. 
Furthermore, Cap1-C26Δ failed to deplete ADP-G-actin, supporting the idea that the 
C-terminal 26 amino acids are important for binding G-actin. These results 
demonstrate that like its S. cerevisiae homologue, the C-terminal half of Cap1 directly 
binds ADP-actin monomers.  
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Figure 3.3.1 Cap1 binds ADP-actin monomers  
Cap1 C-terminal part can pull down ADP-actin from the ADP-actin monomer 
solution in the depletion assay, whereas Cap1 N and Cap1 C26Δ cannot. The S. 
cerevisiae Srv2-N and Srv2-C are used here as positive and negative controls. 
 
 
3.3.2 The N-terminal part of Cap1 binds the adenylyl cyclase Cyr1 in vitro 
 To investigate Cap1-Cyr1 interaction, yeast two-hybrid assays were performed 
(contributed by Dr. Fang Hao-ming). The C-terminal region of Cyr1 (aa 1501-1690) 
was fused to the HA-tagged Gal4 transcriptional activating domain to yield pGBK-
Cyr1-C in plasmid pGBK-T7, while the different regions of Cap1, including the N- 
terminal part (aa 1-284) and the C-terminal part (aa 285-545) were fused to the Myc-
tagged DNA binding domain LexA to yield pGAD-Cap1-N and pGAD-Cap1-C in 
another plasmid pGAD-T7. Pairwise combinations of the plasmids pGBK-Cyr1-C and 
each Cap1 pGAD plasmid were transformed into the yeast strain SFY526 (Fang and 
Wang, 2006). A ‘bait–prey’ interaction would activate the expression of a β-
galactosidase reporter gene, and the yeast cell patches can be stained for the β-
galactosidase activity. Based on the staining results (Fig 3.3.2), the C terminal region 
of Cyr1 was found to interact with Cap1-N but not with Cap1-C. The results are 
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similar to those obtained in the study of Cyr1-Cap1 interactions in S. cerevisiae 
(Shima et al., 2000). 
 
Figure 3.3.2 Association of Cyr1 and Cap1 
Yeast two-hybrid assay shows that Cyr1 C terminal region interacts with Cap1-N, 
while it does not interact with Cap1-C (contributed by Dr. Fang Hao-ming). 
 
 
3.3.3 Cyr1, Cap1 and actin form a complex in vivo. 
 Next, I wished to determine whether Cap1 interacts with actin and Cyr1 in 
vivo. I was particularly interested in determining whether Cap1 can simultaneously 
bind Cyr1 and actin, because such a ternary complex may provide a platform for 
direct cross-regulation between two important cellular processes: cAMP signaling and 
the status of the actin cytoskeleton. For this purpose, co-immunoprecipitation (co-IP) 
assays were carried out. The set of MG-CAP- mutants described in Chapter 3.2 and 
Table 2.1 (Fig3.3.3E) was used. Each of these mutants coexpressed wild-type or a 
mutant form of Cap1 carrying a C-terminal GFP tag with a version of Cyr1 tagged 
with HFM at the N-terminal end; the former was expressed from the native CAP1 
promoter  and the latter from the MET3 promoter. The cap1Δ/Δ strain that expressed 
HFM-Cyr1 alone (strain MG-CAP-2Δ, labeled as cap1Δ/Δ in Fig 3.3.3) was used as a 
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negative control. All strains were cultured in GMM at 30°C overnight, harvested and 
lysed under non-denaturing conditions. Cap1-GFP in cell lysates was first pulled 
down with anti-GFP agarose beads (clone FL from Santa Cruz, CA, USA), and then 
HFM-Cyr1 and actin in the precipitate were probed by Western blotting using Myc 
(clone 9E10 from Roche, Mannheim, Germany) or actin (clone C4) antibodies, 
respectively (Fig 3.3.3B, C, D). The amount of Cyr1, Cap1 and actin in the lysate of 
each strain was first assessed for normalization (Fig 3.3.3A). Co-immunoprecipitation 
of Cyr1 and actin was observed when wild-type Cap1 was pulled down (strain MG-
CAP-wt, labeled as Cap1-wt in Fig 3.3.3B). This result suggests that Cap1 can 
associate with both Cyr1 and actin in vivo, although whether Cap1 binds the two 
proteins separately or simultaneously is still not clear. Since Cyr1 did not 
coprecipitate with Cap1-N30Δ (strain MG-CAP- N30Δ) and Cap1-C (strain MG-
CAP-C) in which the N-terminus of Cap1 was not present, it indicated that the N-
terminal 30 aa of Cap1 is responsible for Cap1’s interaction with Cyr1. Unexpectedly, 
actin was found to coprecipitate with all versions of Cap1 mutants. A plausible 
explanation of this result may be that different domains of Cap1 interact with actin 
patches (F-actin) or actin monomers (G-actin). This hypothesis is supported by my 
observations that the N-terminal 30 aa and the P2 site of Cap1 were required for its 
localization with F-actin (Chapter 3.5.1), while the C-terminal end was required for 
binding G-actin (Chapter 3.3.1). Because all the mutants used in this study retained 
at least one of the actin-interacting domains, it may account for their coprecipitation 
with actin. In order to prove this hypothesis, 10ug/ml Cytochalasin A was added to 
the cell lysates of selected strains (Fig 3.3.3F) to depolymerize the F-actin in the 
lysates, then Cap1 mutants were pulled down and the co-IP HFM-Cyr1 and actin were 
observed. In this condition, the Cyr1-Cap1 coprecipitation was not affected, while 
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unlike the no-drug condition, actin did not coprecipitate with Cap1-C26Δ, suggesting 
the Cap1 C-terminus is the region responsible for G-actin binding.  
Next, HFM-Cyr1 was pulled down by using anti-Myc agarose beads (clone 
A14 from Santa Cruz, CA, USA) (Fig 3.3.3C), followed by Western blotting using 
GFP (clone JL-8 from Clontech, CA. USA) or actin antibodies. Again, Cap1 and Cyr1 
were found to coprecipitate in a manner dependent on the N terminal 30 aa of Cap1. 
Notably, simultaneous co-IP of actin and Cap1 with Cyr1 was detected in three cell 
lysates: Cap1-wt (strain MG-CAP-wt), Cap1-P1Δ (strain MG-CAP-P1Δ) and Cap1-
P2Δ (strain MG-CAP- P2Δ), in each of which both the Cyr1 and G-actin interacting 
domains of Cap1 were intact.  In contrast, neither Cap1 nor actin was detected in 
lysates expressing Cap1-N30Δ (strain MG-CAP- N30Δ) and Cap1-C (strain MG-
CAP-C), in each of which the Cyr1-binding domain of Cap1 was deleted; and only 
Cap1 but not actin was detected in lysates expressing Cap1-N (strain MG-CAP-N) 
and Cap1-C26Δ (strain MG-CAP- C26Δ), in each of which the Cyr1-binding site was 
intact but the G-actin-binding site was deleted. Furthermore, no co-IP of actin and 
Cyr1 was detected in the lysate of cap1Δ/Δ, indicating that there is no direct 
interaction between these two proteins. 
Similar results were obtained when actin was first pulled down and then HFM-
Cyr1 and Cap1-GFP were probed by Western blotting (Fig 3.3.3D), except too much 
nonspecific bands that obscured the signal bands. Cyr1 was detected in lysates 
containing Cap1-wt, Cap1-P1Δ or Cap1-P2Δ with strong bands, but relatively weak in 
those containing Cap1-N, Cap1-N30Δ, Cap1-C, or Cap1-C26Δ. The short of the clear 
no-interaction of actin and Cyr1 may probably due to the high abundance of actin in 
cell lysates which resulted in strong nonspecific binding.  
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Figure 3.3.3 Cyr1, Cap1 and actin interactions in vivo. (A) Amounts of Cyr1, Cap1, 
and actin in total cell lysates were assessed using antibodies against Myc, GFP, and 
actin respectively by Western blotting. (B) IP was performed using anti-GFP beads 
and Western blots were probed with Myc and actin antibodies. (C) IP was done using 
anti-Myc beads and Western blots were probed with GFP and actin antibodies. (D) IP 
was done using anti-actin beads and Western blots were probed with Myc and GFP 
antibodies. (E) Schematic descriptions of Cap1 mutants. (F) IP was performed using 
anti-GFP beads and Western blots were probed with Myc and actin antibodies just 
like panel B except treating the cell lysates with 10ug/ml Cyto A 30min in room 
temperature before IP. Results from panel B, C and D showed that deletion of CAP1 
abolishes the interaction between Cyr1 and actin, and deletion of Cap1 N-terminus or 
C-terminus also abolishes the interaction between Cyr1 and actin. The results thus 
indicate that Cap1 bridges Cyr1 and actin in a ternary complex. However, deletion of 
P1 or P2 regions does not affect the Cyr1-actin interaction.  
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Based on all the results above, we propose that Cap1, Cyr1 and G-actin form a 
complex in which Cap1 acts as a bridge. The loss of Cyr1-actin interaction in cells 
where the G-actin binding domain of Cap1 was deleted suggests that although Cap1 
can interact with F- and G-actin, it only interacts with G-actin in the Cyr1/Cap1/actin 
complex.  
 
3.4 Influence of Cap1 on the actin cytoskeleton 
3.4.1 Subcellular locations of Cap1 
 Cellular localizations of GFP-tagged Cap1 proteins (the G-CAP- set described 
in Chapter 3.2 and Table 2.1, simply labeled as CAP- in Fig 3.4.1) were examined in 
log-phase yeast cells. Cells were stained with rhodamine-phalloidin to visualize F-
actin structures. The results are shown in Figure 3.4.1A. Like its homologue Srv2 in S. 
cerevisiae, full length wild-type Cap1 (strain G-CAP-wt) colocalized with actin 
patches. However, Cap1-N30Δ (strain G-CAP-wt) and Cap1-C (strain G-CAP-C) 
were evenly distributed in cytoplasm, indicating that the N-terminus is required for 
Cap1’s association with actin patches. The cytoplasmic localization of these two 
mutants is not due to the failure of their interactions with Cyr1, because full length 
Cap1 exhibited normal actin-patch localization in cyr1Δ/Δ cells (strain 
cyr1Δ/Δ:CAP1-GFP) (Fig 3.4.1B). This result, consistent with previous observations 
in S. cerevisiae (Bertling et al., 2004), indicates that interactions with Cyr1 and with 
actin-patches are two independent functions of the N-terminus of Cap1. Interestingly, 
unlike Srv2 where the P2 site is essential for actin-patch localization (Freeman et al., 
1996), the two mutants Cap1-P2Δ (strain G-CAP-P2Δ) and Cap1-N (strain G-CAP-N) 
that lack the P2 site were found to colocalize with actin patches. However, the pattern 
of actin patches appeared abnormal in these mutant cells (Fig 3.4.1A): Each cell 
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contained one or two predominantly large patches, suggesting that the P2 site of Cap1 
may have a role in actin-patch assembly.  In S. cerevisiae, the P2 site is proposed to 
bind Abp1 and thus mediates Srv2 association with F-actin (Freeman et al., 1996). 
Does Abp1 mediate Cap1’s actin patch localization in C. albicans? To address this 
question, I next examined Cap1-GFP localization in abp1Δ/Δ mutant 
(abp1Δ/Δ:CAP1-GFP). I found that the patterns of actin patch staining and Cap1-GFP 
localization in abp1Δ/Δ cells were largely similar to those in wild-type cells except 
that the intensity of GFP fluorescence was markedly weaker compared with wild-type 
cells. Long exposure is needed to get GFP signals in Figure 3.4.1C, suggesting that 
Abp1 is involved in but not fully responsible for Cap1’s association with actin patches. 
Moreover, in the abp1Δ/Δ mutant , large F-actin patches were not formed resembling 
those seen in CAP-P2Δ cells (Fig 3.4.1D), indicating that Cap1 has a role in 
regulating actin patches in C. albicans, and this role requires the P2 site and partially 
depends on Abp1. Although the N-terminal end of Cap1 is required for Cap1-GFP 
localization to actin patches and deletion of the P2 site affects the pattern of actin 
patches, deletion of the C-terminal 26 aa (strain G-CAP-C26Δ) or the P1 site (strain 
G-CAP-P1Δ) had discernible effect neither on Cap1’s actin patch localization nor on 
actin patch patterns (Fig 3.4.1A), suggesting that Cap1’s roles in regulating the 
functions of F-actin and G-actin are separated.   
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Figure 3.4.1 The cellular localization of Cap1  
 
(A) Schematic descriptions of Cap1 mutants and their cellular localizations. Cells 
were stained with rhodamine-phalloidin to visualize actin patches. Wild-type Cap1 
showed actin-patch localization; Cap1-N30Δ and Cap1-C showed no special 
localization; Cap1-N and Cap1-P2Δ showed special pattern of actin patches; And 
Cap1-C26Δ and Cap1-P1Δ showed similar GFP localization and actin patch pattern as 
wild type. (B) Cap1 localization in cyr1Δ/Δ (C) Cap1 localization in abp1Δ/Δ (D) 
Actin-patch pattern in cap1Δ/Δ. This pattern is similar to the pattern in CAP-N or 
CAP-P2Δ. 
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3.4.2 Some other aspects of Cap1 influence on the actin cytoskeleton. 
Since actin plays important roles in endocytosis, I hypothesized that the 
abnormal actin patches observed in CAP-2Δ  (both CAP-2Δ-1 and -2 strains), CAP-N 
and CAP-P2Δ cells may affect endocytosis (Ayscough, 2005a; Ayscough, 2005b; 
Kaksonen et al., 2003). To test his hypothesis, I used two commonly used endocytic 
markers Lucifer yellow and FM4-64: the former was used to evaluate the fluid phase 
endocytosis and the latter was used to trace the entire endocytic process (Kim et al., 
2006). I found that 1 hr after adding Lucifer yellow to the cell cultures, the dye was 
found to have accumulated in vacuoles in both wild type and mutants (CAP-2Δ and 
CAP-P2Δ)  to a similar extent (Fig 3.4.2A), suggesting that the fluid phase 
endocytosis is not affected in these mutants. However, FM4-64 was found to 
accumulate only on the cytoplasmic membrane in CAP-2Δ and CAP-P2Δ cells, and 
localization of the dye to endocytic vesicles were not observed during the first 20 min; 
this was in stark contrast to wild-type cells in which membranes of the endocytic 
vesicles were clearly stained by the dye and the number of stained endocytic vesicles 
increased with time (Fig 3.4.2B). These results suggest that the internalization step of 
endocytosis may be impaired in CAP-2Δ and CAP-P2Δ mutants. 
 
Chapter3 Characterization of C. albicans Cap1 and Its Function in Morphogenesis 
 71
 
Figure 3.4.2 Cap1 regulation of endocytosis  
(A) Lucifer yellow uptake:  Lucifer yellow (LY) dilithium salt was added to the log-
phase yeast cells to a final concentration of 1 mg/ml. After 2-hr incubation at room 
temperature, cells were observed using the FITC channel of fluorescence microscope. 
The arrow shows a dot that may reflect the GFP fluorescence of CAP-P2Δ. (B) Time-
lapse of FM4-64 labeling: FM4-64 dye was added to log-phase yeast cells at the final 
concentration of 40 µM. The cells were immediately observed using the rhodamine 
channel and photos were taken every 2 min at room temperature. While wild-type 
cells show FM4-64 localization to the endocytic vesicles, the mutant cells only show 
plasma membrane localization of the dye.  
 
 
3.5 Role of Cap1 in Cyr1 activation 
3.5.1 Cap1 N-terminal part is not sufficient for optimal control of cellular cAMP 
levels during hyphal induction. 
 As reviewed in Chapter 1.5.3, based on results from S. cerevisiae, Cap1 is 
thought to regulate Cyr1 activity by its N terminal part. To evaluate the role of the N-
terminal part of Cap1 in regulating Cyr1 activity during C. albicans hyphal growth, 
the cAMP level in CAP-N (strain MG-CAP-N) cells was measured in comparison 
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with wild type (strain MG-CAP-wt). Like the  previous reports (Bahn and Sundstrom, 
2001; Fang and Wang, 2006), wild-type cells showed a sharp increase in intracellular 
cAMP levels under 10% serum induction in GMM medium, which peaked at ~30 min 
with a ~2.5-fold rise and then decreased slowly over an extended period. In 
comparison, the mutant CAP-N produced an attenuated cAMP spike, which peaked at 
~1 hr with a ~1.7-fold increase, showing that the N-terminal part alone is insufficient 
for the cell to produce the optimal level of intracellular cAMP in response to hyphal 
induction (Fig 3.5.1). The data agree with the mild hyphal defects observed in 
mutants with various deletions in the C-terminal half of Cap1 (Chapter 3.6.2), 
suggesting that the C-terminal part of Cap1 may also have a role in the proper 
activation of Cyr1. 
 
Figure 3.5.1 Increase of cellular cAMP levels during serum-induced hyphal 
growth 
 
Yeast cells were grown in GMM at 30°C overnight before diluted 5 times into GMM 
containing 10% serum. Aliquots of cells were harvested at 0, 15, 30, 45, 60 and 120 
min after induction at 37°C. The intracellular levels of cAMP were determined as 
described in Chapter 2.9.1. The cAMP level at 0 min of each strain is treated as 1 and 
those at later time points are presented as fold increase. All data represent mean 
values of 3 independent experiments and standard deviations are shown. 
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3.5.2 Cap1 C-terminal part is required for optimal cAMP production during 
hyphal growth. 
 Although the results above suggest that Cap1 C-terminal part is required for 
the optimal activation of Cyr1, cells expressing Cap1 C-terminal part alone (strain 
MG-CAP-C) exhibited only a slight increase in cAMP level upon induction (Fig 3.5.1) 
and severe hyphal growth defects. There are at least two possible ways for the C-
terminal part to contribute to Cyr1 activation. First, it may be required for the proper 
folding of Cap1’s N-terminal part; and second, it may have a direct role in the 
activation but need the N terminal part to bring it in contact with Cyr1. To address 
these possibilities, a fusion construct Cyr1-Cap1-C was generated in which the C-
terminal part of Cap1 (aa 285-545) was fused to the C-terminal end of Cyr1 and 
expressed in a strain as the only source of Cap1 and Cyr1 (strain CCC).  A control 
strain CCM (Cyr1-Cap1-Cmut) was constructed in the same manner except that the 4 
highly conserved residues Glu520, Pro524, Glu525 and Gln527 at the C-terminus of Cap1 
were replaced with Ala (Fig 3.5.2A&B) to disrupt the G-actin-binding site (Chapter 
3.3.1). The genotypes of all these strains were confirmed by PCR analysis of the 
genomic DNA (Fig 3.5.2C). 
Next, cAMP levels in these mutants were measured under hyphal induction 
conditions. The results showed that strain CCC responded to serum induction and, 
like strain CAP-N, produced a delayed and lower cAMP spike compared with the 
wild-type strain. In contrast, strain CCM showed only a slight increase of the cAMP 
level (Fig 3.5.2D). Furthermore, the CCC construct also significantly restored 
filamentous growth in the cap1Δ/Δ mutant (strain MG-CAP-2Δ), while CCM did it 
moderately (Fig 3.5.2E). Taken together, these results show that the C-terminal part 
of Cap1 indeed plays a direct role in activating Cyr1. This role is independent of the 
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N-terminal part of Cap1 but needs it to facilitate its interaction with Cyr1. 
Furthermore, Cyr1 activation by the C-terminal part of Cap1 depends on its 
interaction with G-actin.  
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Figure 3.5.2 The influence of Cap1 C-terminal part in Cyr1 activation 
(A) Schematic description of the construction of strains CCC and CCM. (B) Strategy 
for fusing Cap1 C-terminal part to the C-terminal end of Cyr1. (C) Analysis of CCC 
and CCM strains by genomic DNA PCR: The pair of primers for amplifying CYR1-
CAP1 is CYR-6110F and CAP-P2ΔR, and the primers for ACT1 are ACT-F and 
ACT-R. (D) Cellular cAMP levels induced with 10% serum at 37°C. (E) The 
morphologies of these strains after 3-hr induction by 10% serum at 30°C. WT 
represents strain MG-CAP-wt. 
 
3.6 Effects of the Cap1 mutants on cell morphology 
3.6.1 Effects on yeast cells 
 In S. cerevisiae, SRV2 deletion affects yeast cell growth in 4 major aspects: 
inability to grow on rich medium, temperature sensitivity on minimal medium, 
sensitivity to nitrogen deprivation, and changes in cell morphology (Hubberstey and 
Mottillo, 2002). The first three are thought to be the results of impaired cAMP 
production, while the last one is thought to be due to defects in actin regulation. To 
understand Cap1’s role in C. albicans yeast growth, the cap1Δ/Δ mutant (strain MG-
CAP-2Δ) was grown in the rich medium YPD compared with growth in the glucose 
minimal GMM at 30°C (Fig 3.6.1A). The mutant was found to grow as well as wild 
type on both media. Thus, unlike in S. cerevisiae, lacking Cap1 does not affect C. 
albicans growth in rich medium.  
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 Then the morphology of different Cap1 mutants was examined. I found that in 
contrast to the oval shape of wild-type yeast cells, cells of all the Cap1 mutants were 
round (Fig 3.6.1B), consistent with roles of Cap1 in actin cytoskeleton regulation and 
this role appears to require all the functional domains deleted.  
 
 
Figure 3.6.1 Effects of Cap1 mutants on yeast cells 
(A) The growth of wild type (SC5314) and CAP-2Δ (cap1Δ/Δ, or MG-CAP-2Δ) on 
YPD and GMM plates at 30°C. Serially-diluted yeast cells were dropped onto the 
agar plates and grown at 30°C for 2 days. (B) Typical yeast cell morphology for wild 
type and Cap1 mutants (represented by MG-CAP-2Δ). Since the yeast cells of all the 
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3.6.2 Effects of Cap1 mutants on HU-induced filamentous growth 
 Perturbation of cell-cycle progression may cause pseudohyphal growth of C. 
albicans. For example, 50 mM hydroxyurea (HU), a DNA-replication inhibitor, can 
induce significant cell elongation in YPD medium at 30°C (Shi et al., 2007). This 
type of filamentous growth does not depend on the cAMP/PKA and MAPK pathways 
that control the hyphal growth. However, I found that deletion of CYR1 (strain 
cyr1Δ/Δ) abolishes the HU-induced elongation, which cannot be rescued by adding 
the membrane-permeable dibutyryl cAMP (10 mM db-cAMP), suggesting that Cyr1 
has a role in the HU-induced filamentous growth which does not depend on increased 
cAMP levels (Fig 3.6.2A). As a partner of Cyr1, the role of Cap1 in the HU-induced 
filamentous growth was also investigated. I found that like CYR1, deletion of CAP1 
(strain MG-CAP-2Δ) severely impaired the HU-induced filamentous growth, and the 
defect could not be rescued by externally added db-cAMP. The CAP-N and CAP-C 
mutants could partially rescue the defect (Fig 3.6.2B). After overnight induction, the 
average length of the wild-type cell chain was 42.64 µm (n = 100), while that of 
cap1Δ/Δ cells was only 16.26 µm; and the average cell chain length was 28.26 µm for 
CAP-N and 18.87 µm for CAP-C. These preliminary results suggest that Cyr1 and 
Cap1 play an important role in the HU-induced filamentous growth which may not be 
directly related with cAMP production. 
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Figure 3.6.2 Effects of CYR1 and CAP1 mutants on HU-induced filamentous 
growth 
 
(A) Deleting CYR1 (cyr1Δ/Δ) abolishes the HU-induced filamentous growth. 
5×105/ml cells were grown in YPD medium containing 50 mM HU at 30°C. 
Filamentous growth was observed at 3 hr, 6 hr and overnight (o/n). To one culture, 10 
mM db-cAMP was added. (B) cap1Δ/Δ (MG-CAP-2Δ) is also defective in HU-
induced filamentous growth. CAP-N and CAP-C can only partially rescue the defect. 
 
 
3.6.3 Effects of Cap1 mutants on hyphal growth 
 Hyphal growth is defective in the cap1Δ/Δ mutant and the defect can be 
rescued by adding external db-cAMP under hyphal-inducing conditions (Bahn and 
Sundstrom, 2001), indicating that Cap1’s Cyr1 regulating activity instead of its actin-
regulating activity plays the essential role in hyphal growth. The result seems to imply 
that the two functions of Cap1 are separable. However in this section, I will provide 
data to show that the C-terminal domain of Cap1 has an actin-dependent role in 
regulating hyphal growth.  
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I first examined all the CAP1 mutants (the MG- set of strains) for their ability 
of hyphal growth under serum induction. All strains were induced in GMM + 10% 
serum at 37°C for 2 hr. As shown in Figure 3.6.3.1, based on the hyphal growth 
pattern, the CAP1 mutants can be divided into two groups. The first includes CAP-
2Δ (cap1Δ/Δ), CAP-N30Δ, and CAP-C: these mutants were severely defective in 
hyphal growth, indicating that the Cyr1-binding domain at the N terminus is of critical 
importance for hyphal growth. The second group includes CAP-P1Δ, CAP-P2Δ, 
CAP-N and CAP-C26Δ. Although these mutants exhibited hyphal growth, the 
diameter of hyphal cells was markedly greater than wild type. The hyphal defects of 
CAP-N and CAP-C26Δ became stronger, when the serum concentration was reduced 
to 4%. The results suggest that the C-terminal part, especially the C-terminal 26 
amino acids, also contribute to proper hyphal growth particularly under weaker 
induction conditions.  
I also examined hyphal growth of the CAP1 mutants in some other inducing 
conditions including RPMI medium, Lee’s medium, Spider plates and embedding 
conditions. Figure 3.6.3.2 shows the results. In RPMI and Lee’s liquid media, the 
hyphal growth patterns were similar to those in 4% serum, indicating Cap1 C- 
terminus is also required for normal hyphal growth in these two conditions. On Spider 
plates, only CAP-P1Δ exhibited wild-type-like filamentous growth, while all other 
mutants formed colonies with a smooth edge. Under the embedding condition, the 
extent of filamentous growth of CAP-P1Δ, CAP-P2Δ, CAP-N and CAP-C26Δ were 
similar to wild type, while CAP-2Δ, CAP-N30Δ, and CAP-C were severely defective. 
Together, the results reveal that besides the key importance of the N-terminus of Cap1 
for hyphal growth the C-terminus is required for optimal hyphal or filamentous 
growth under most of the conditions used above.  
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Figure 3.6.3 Hyphal growth of CAP1 mutants under serum induction. 
Yeast cells of all strains were induced in GMM supplemented with 10% or 4% serum 
at 37°C for 1 or 2 hr. Wild type is represented by MG-CAP-wt. 
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Figure 3.6.3.2. Hyphal growth of CAP1 mutants in RPMI medium, Lee’s 
medium, Spider plate and embedding conditions 
Yeast cells of all strains were induced in RPMI or Lee’s liquid media at 37°C for 2 hr, 
or on Spider plates or under embedding condition at 30°C for 72 hr. 
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3.7 Summary 
 In this chapter, C. albicans Cap1 was characterized and its role in 
morphogenesis was investigated. First, I studied the interaction of Cap1 with its two 
important partners Cyr1 and actin both in vitro and in vivo. I found that Cap1 interacts 
with Cyr1 through its N terminus and with ADP-G-actin monomers through its C 
terminus. I also found that Cyr1, Cap1 and actin monomers in vivo form a ternary 
complex in which Cap1 acts as a bridge. Then, I investigated certain cellular aspects 
regarding interactions of Cap1 with the actin cytoskeleton. Cap1-GFP was found to 
colocalize with cortical actin patches, and Cap1’s N terminus was important for this 
localization. Deletion of CAP1 or the P2 site caused aggregation of F-actin into one or 
two dominant actin-bodies in the cell and impairment of the internalization step of 
endocytosis based on staining of cells with the lipophilic dye FM4-64. However, 
deletion of the C terminus of Cap1 had discernible effect neither on Cap1’s actin 
patch localization nor on actin patch patterns, suggesting that the Cap1’s F-actin (P2 
site) regulating function is separated from its G-actin (C terminus) regulating function. 
Next, I investigated Cap1’s role in controlling cellular cAMP levels. I found 
that although the N-terminal part of Cap1 was crucial for producing the cAMP spike 
in cells in response to hyphal induction, in the absence of the C-terminal 26 amino 
acids the cAMP spike was delayed and its peak level was reduced significantly. I then 
found that when fused to the C-terminal end of Cyr1, the C-terminal half of Cap1 
could partially activate cAMP production upon hyphal induction, resulting cAMP 
peak similar to that observed in cells expressing the N-terminal half of Cap1; and this 
activity was largely abolished when four conserved residues in the G-actin binding 
site were mutated. Thus, the results indicate that the C-terminal region of Cap1 has a 
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direct role in regulating cAMP production and this activity may depend on its 
interaction with actin monomers.  
I also examined the effect of the various CAP1 mutants on cell morphology 
under a range of growth conditions. I found that deletion of CAP1 resulted in round 
yeast cells and impaired the HU-induced filamentous growth. More interestingly, 
during hyphal induction, mutants lacking the C-terminus of Cap1 showed significant 
hyphal growth defects under certain induction conditions such as in media containing 
low concentrations of serum and in RPMI and Lee’s media, indicating that the C-
terminal region indeed plays a role in hyphal growth. Taken together, based on the 
ternary structure of Cyr1, Cap1 and G-actin, and the observed roles of Cap1’s C 
terminus in regulating cAMP production and hyphal growth, I propose that actin 
monomers participate in Cyr1 activation through interaction with Cap1. 
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CHAPTER 4  
The Cellular Status of Actin Cytoskeleton Affects the cAMP 
Signaling Pathway through Cap1 
4.1  Introduction 
 It has been known that chemical or genetic interference of the actin 
cytoskeleton impairs the transcriptional activation of hypha-specific genes. For 
example, hyphal induction can only partially activate the transcription of HSGs in 
cells treated with the actin polymerization inhibitor LatA (Hazan and Liu, 2002). And 
strains expressing certain mutant versions of Cdc42 that alter actin polarization also 
exhibit reduced expression of HSGs in response to serum induction (Ushinsky et al., 
2002). These observations suggest that the signaling pathways for hyphal growth may 
be influenced by the status of the actin cytoskeleton, although the underlying 
mechanism remains unknown. 
In the previous chapter, I showed that the G-actin binding domain of Cap1 was 
important for the full activation of the adenlyly cyclase Cyr1 in response to hyphal 
induction. Furthermore, I found that Cyr1, Cap1 and G-actin form a ternary complex. 
It therefore appears reasonable to speculate that actin monomers might be able to 
influence Cyr1 activity through its interaction with Cap1, thereby providing a 
mechanistic link between the cellular actin status and the cAMP signaling pathway. 
To test this hypothesis, we investigated the effect of LatA and other actin-interacting 
drugs on the activation of the cAMP signaling pathway in strains expressing versions 
of Cap1 lacking the G-actin-binding domain.  
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4.2  External cAMP alleviates the inhibitory effect of LatA on the 
expression of HSGs  
 I first examined the mRNA levels of four HSGs including HWP1, ECE1, 
HYR1 and HGC1 by RT-PCR during hyphal induction in the presence or absence of 
LatA in wild-type (G-CAP-wt) strain (Fig 4.2A). While the mRNA of all four genes 
was hardly detectable in yeast cells, strong transcriptional activation was detected 
after 1 hr of induction at 37°C in YPD supplemented with 10% serum. In comparison, 
adding 200 µM LatA to the inducing medium markedly reduced the transcription 
activation of all the four HSGs. When 10 mM db-cAMP was added together with 
LatA, the activation was partially restored. As a control, the expression of ACT1 was 
not affected by any of the conditions used. I next performed real-time RT-PCR to 
quantify levels of HSG activation under different inducing conditions. The results 
showed that adding LatA to the induction medium reduced the levels of HSG 
activation to 2-8% of the normal induction level, whereas adding db-cAMP together 
with LatA restored the activation to 15-35% (Fig 4.2B). Together, the results suggest 
that LatA affects HSGs expression through the cAMP signaling pathway. While I was 
doing these experiments, similar observations on the expression of HWP1 were 
reported (Wolyniak and Sundstrom, 2007). 
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Figure 4.2 The effect of LatA on expression of HSGs and the role of Cap1 in this 
process.  
(A) The mRNA levels of HWP1, ECE1, HYR1 and HGC1 were analysed by RT-PCR 
in cells grown under various conditions:  
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Y, yeast growth; H, 2-hr hyphal induction with 10% serum at 37°C; H+L, 2-hr hyphal 
induction with 10% serum at 37°C in the presence of 200 µM LatA; and H+L+cAMP, 
2-hr  hyphal induction with 10% serum at 37°C in the presence of 200 µM LatA and 
10 mM db-cAMP. The strains used in this experiment were wild type (G-CAP-wt) 
and CAP-N. The mRNA level of ACT1 was used for normalization. ‘Neg’ indicates 
negative controls in which RNA samples were directly used as templates for PCR. (B) 
Quantitative real-time RT-PCR analysis of LatA’s effect on HSG expression in wild-
type cells grown in the same conditions as described in A. The mRNA level of each 
gene in cells grown in each condition is presented as a percentage of that of the same 
gene induced in the H condition. (C) The experiment described in B was repeated 
using the CAP-N cells. 
  
4.3  The effect of LatA on HSG expression partly depends on the C-
terminal part of Cap1  
Because the results in Chapter 3 suggest that Cap1 bridges Cyr1 and G-actin 
in a ternary complex, I wished to determine whether Cap1 plays a role in LatA’s 
effect on HSG expression. To this end, I repeated the experiments above using a strain 
expressing Cap1-N as the sole source of Cap1 (G-CAP-N). As shown in Figure 4.2A, 
the HSGs in this strain exhibited similar levels of transcriptional activation as in wild 
type. However, the HSG expression was significantly less sensitive to LatA: the levels 
were decreased to 16-27% of those detected in the normal induction condition 
compared with only 2-8% in wild-type cells (Fig 4.2 B&C). These data show that 
without the C terminal half of Cap1, the effect LatA on HSG’s expression was 
significantly reduced. 
To further understand the role of the C-terminal part of Cap1 in the effect 
LatA on HSG activation, I used the CCC strain that expresses the C-terminal half of 
Cap1 fused to the C-terminal end of Cyr1. In this strain the Cyr1-Cap1-C fusion 
protein is the only source of Cap1. Figure 4.3A shows that unlike strain CAP-N, 
strain CCC exhibited similar sensitivity to LatA in the transcriptional activation of 
HWP1 and ECE1 as the wild type. The results indicate that first, when directly linked 
Chapter4 The Cellular Status of Actin Cytoskeleton Affects the cAMP Signaling Pathway through Cap1 
 88
to Cyr1, the C-terminal half of Cap1 allows full activation of HWP1 and ECE1 
transcription upon hyphal induction; and second, the C-terminal half contains regions 
important in mediating the effect of LatA on the expression of HSGs. I then examined 
HSG expression in strains CAP-P1Δ, CAP-P2Δ and CAP-C26Δ (G- set) expressing 
Cap1 mutants deleted of the P1, P2 and the very C-terminus region respectively by 
quantitative Real-time RT-PCR (Fig 4.3B). For hyphal induction in the presence of 
LatA, I did not detect any obvious diference between wild type and CAP-P1Δ or 
CAP-P2Δ, suggesting that interaction of Cap1 with F-actin has no obvious roles in 
regulating cellular HSG levels. However in strain CAP-C26Δ, the HSG level in the 
presence of LatA was 5~10 times higher than that in wild type. The resistance of 
CAP-C26Δ to LatA suggests the G –actin binding motif of Cap1 is responsible in 
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Figure 4.3 The effect of LatA on thr expression of HSGs in strains of Cap1 C- 
terminal part mutants  
 
(A) RT-PCR analysis of mRNA levels of HWP1 and ECE1. H, 2-hr inducrtion with 
10% serum at 37°C; H+L, 2-hr induction with 10% serum at 37°C in the presence of 
200 µM LatA;  H+L+cAMP, 2-hr induction with 10% serum at 37°C in the presence 
of both 200 µM LatA and 10 mM db-cAMP. The strains used for this assay were wild 
type and CCC. ACT1 mRNA was used for normalization. ‘Neg’ represents the 
negative control in which RNA samples were used directly as PCR templates. (B) 
Quantitative real-time RT-PCR analysis of LatA’s effect on HWP1 and ECE1 
expression in wild-type, CAP1-P1Δ, CAP1-P2Δ, and CAP1-C26Δ cells. The mRNA 
level of each gene induced in the presence of LatA (H+L) is presented as a percentage 
of that of the same gene induced in the absence of LatA (H). 
 
 
4.4  LatA and other actin-binding drugs affected cAMP production 
in cell lysates 
Studies in the above sections suggest that the transcriptional repression of 
HSGs by LatA is partially dependent on cAMP signaling and the direct interaction of 
Cap1 with G-actin. Next, I wanted to determine whether LatA affects cAMP 
generation. To do this, I performed assays that directly measure the adenylyl cyclase 
activity in cell lysates. Wild-type cells (G-CAP-wt) were lysed by bead-beating under 
non-denaturing conditions and the total lysate was mixed with reaction buffer 
containing α-32P-ATP. After 30 min of reaction at room temperature, the generated 
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32P-cAMP was purified and quantified by scintillation counting. As shown in Figure 
4.4A, although the experimental temperature is around 25°C not the usual inducing 
temperature (37°C), the reaction yielded a 4-fold increase in the amount of cAMP 
than the control reaction without serum at 30 min after adding 10% 3k (the 3k serum 
filtrate of serum). When LatA was added together with serum, the amount of cAMP 
produced in the reaction was significantly reduced in a manner dependent on LatA 
concentrations. At 200 µM, the cAMP level was reduced almost to the control level, 
indicating that LatA has a direct influence on cAMP synthesis. Next, cAMP 
production in the lysate of strain CAP-C26Δ (G-CAP- C26Δ) was assayed. This lysate 
exhibited a 2.5-fold increase in cAMP levels after 30 min of treatment with serum, 
which is lower than the wild-type lysate and is consistent with the results of the 
measurement of intracellular cAMP levels (Fig. 3.5.1). Strikingly, LatA at 
concentrations up to 200 µM had little effect on the cAMP production induced by 
serum, indicating that the G-actin-binding motif at the C-terminal end of Cap1 plays 
an important role in mediating the effect of LatA on cAMP production.  
I next examined whether another actin-binding drug Cytochalasin A (Cyto-A) 
also has effect on cAMP production. As shown in Figure 4.4B, similar to the LatA 
treatment, in wild-type cell lysates, when Cyto-A was added together with 3k serum 
filtrate, the amount of cAMP produced in the reaction was significantly reduced in a 
manner dependent on Cyto-A concentrations. In contrast, in the CAP-C26Δ strain, the 
effect of Cyto-A on cAMP production was significantly impaired. 
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Figure 4.4  cAMP production in cell lysates 
(A) cAMP synthesis in cell lysates. The reactions were carried out at room 
temperature for 30 min in the absence (control) or the presence of 10% serum (the 3k 
serum filtrate was used) and different concentrations of LatA. Lysates of wild type 
and CAP-C26Δ strains were compared. The cAMP levels (32P-cAMP) are presented 
as fold increases compared with that of the controls. (B) The experiments described in 
A were repeated using Cyto-A to replace LatA. 
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4.5 LatA and Cyto-A affect cAMP production in purified 
Cyr1/Cap1/actin complex 
 Since Cyr1, Cap1 and actin can be purified as a complex, it provides an 
opportunity to test whether the complex has the ability to increase cAMP production 
in response to serum treatment and how alterations of the actin-Cap1 interaction affect 
cAMP production in the purified system. The Cyr1/Cap1/actin complex was pulled 
down from lysates of cells expressing Cyr1-HFM and assayed for cAMP production 
with the method described in Chapter 4.4. I found that serum can significantly 
activate cAMP production by the protein complex even at room temperature (Fig 
4.5A), indicating that the complex contains all essential components required for 
increasing cAMP production in response to serum treatment. Furthermore, the 
activation of cAMP production in this system was also blocked by LatA and Cyto-A 
(Fig 4.5B&C). In comparison, the complex immunopurified from cells expressing 
Cyr1-HFM and Cap1-C26Δ exhibited reduced activation of cAMP production under 
serum treatment, and this activation was insensitive to LatA and Cyto-A treatments. 
Taken together, the results provide compelling evidence that actin plays a direct role 
in activating cAMP production by Cyr1 and this activation requires Cap1.  




Figure 4.5 cAMP production by affinity-purified Cyr1-containing complex in 
vitro 
 
(A) 32P-cAMP production by immunbopurified Cyr1-containing complexes. Cyr1-
HFM was pulled down using anti-Myc antibody from wild-type and CAP-
C26Δ strains under non-denaturing conditions, and the pull-down products were used 
in in vitro cAMP synthesis assays. 32P-cAMP production assay was performed at 
room temperature in the absence (control) or presence of 10% 3k serum filtrate, and 
the amount of 32P-cAMP was determined at 0, 10, 20, 30 min. The 32P-cAMP levels 
are presented as fold increase compared with that at 0 min. (B) Experiments described 
in A were repeated at the time point 30 min by including 200 µM LatA in the 
indicated reactions. (C) Experiments described in B were repeated by using 2 µg/ml 
Cyto-A to replace LatA. 
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4.6 Investigation of how the actin toxins affect Cyr1 activity through 
Cap1 
 The effect of LatA and Cyto-A on the adenylyl cyclase activity suggests that 
the growth switch from yeast to hyphae may involve changes in the equilibrium 
between F- and G-actin pools in the cell. To address this issue, I used rhodamine-
phalloidin to stain F-actin in cells induced with serum at 37°C for 15, 30 and 45 min 
and then used fluorescence-activated cell sorting (FACS) to detect changes in cellular 
fluorescence intensity that was expected to have a positive correlation with the total 
amount of cellular F-actin (Fig 4.6A). However, no significant change was detected. 
There are several possible explanations of the result. First, previous work indicated 
that in yeast cells ~99% of actin molecules are in the filamentous form (Ayscough, 
2000); thus, if there were an increase of F-actin during hyphal growth, the percent 
increase would be too small for FACS to detect. Second, it is also possible that during 
hyphal growth, short actin filaments are assembled into longer bundles, a change that 
could not have been detected by the FACS analysis either. Third, hyphal induction 
may have little to do with changes in G-actin and F-actin pools. Next, I examined the 
effect of the F-actin-stabilizing reagent jasplakinolide (Jasp) (Scott et al., 1988) on 
cAMP production. Wild-type cells were treated for 2 hr with 0.1 µM Jasp, a 
concentration sufficient to cause actin aggregation in C. albicans cells. I found that, 
first, there was no significant difference in the basic cAMP level compared with 
untreated cells (Fig 4.6B), and second, the drug-treated cells exibited similar increase 
in cAMP levels as untreated cells during hyphal induction (Fig 4.6C). Thus 
stabilization of F-actin does not seem to have significant effect on Cyr1 activation.  
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Next, I asked whether the actin toxins affect the interaction of actin with Cap1 
in the Cyr1/Cap1/actin complex. To this end, I prepared cell lysates from the yeast 
cells of strain MG-CAP-wt and treated them with 10% of 3k serum filtrate at 37°C for 
30 min in the absence or presence of 2 µg/ml Cyto-A before immunoprecipitating 
HFM-Cyr1 using a Myc-antibody. Actin and Cap1-GFP in the precipitates were then 
detected by Western blotting using actin and GFP anbodies respectively (Fig 4.6D). 
The results showed that Cyto-A treatment significantly increased the amount of actin 
in the ternary complex, suggesting that increase of G-actin in the complex might have 
an inhibitory effect on the activation of Cyr1 during hyphal induction. However, in 
similar experiments using LatA, there was no obvious change in the amount of actin 
in the ternary complex (Fig 4.6E). The results suggest that the effect of LatA and 
Cyto-A is not caused by dissociation of G-actin from the ternary complex. I 
hypothesize that binding of the actin drugs to G-actin in the ternary complex may 
cause conformational changes that impair the activation of the adenylyl cyclase. 
Further structural studies are required to test this hypothesis.  
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Figure 4.6  Investigation of how the actin toxins affect Cyr1 activity through 
Cap1 
 
(A) Quantitation of F-actin in wild-type (SC5314) yeast and hyphal cells. The amount 
of rhodamine-phalloidin stained F-actin was determined by using FACS analysis. An 
overnight yeast culture was split into two in GMM, and then one was grown at 30°C 
as yeast and the other was induced with 10% serum at 37°C. Aliquots of cells were 
collected at 15, 30 and 45 min. (B) Cellular cAMP levels (pmol per mg dry cell 
weight) of wild-type yeast cells grown for 2 hr at 30°C in the absence or presence of 
0.1 µM Jasplakinolide (Jasp). (C) Cellular cAMP levels in hyphal cells induced with 
10% serum at 37°C in the absence or presence of 0.1 µM Jasp. (D) co-IP of Myc-
Cyr1 with Cap1-GFP and actin. Cell lysates were prepared from yeast cells of strain 
MG-CAP-wt and equal volumns of the lysates were treated with the following 
conditions: lane C, the lysates were directly subjected to IP; lane H, 10% 3k serum 
filtrate was added to the lysate and incubated at 37°C for 30 min before IP; and lane 
H+C, 2 µg/ml Cyto-A together with 10% 3k serum filtrate was added to the lysates 
and incubated at 37°C for 30 min before IP. Then HFM-Cyr1 from the above 
untrearted and treated lysates was immunoprecipitated by using anti-Myc antibody, 
followed by Western-blot detection of Cap1-GFP and actin by using GFP and actin 
antibody, respectively. All IP experiments were done by mixing antibody-conjugated 
beads with the lysate for 2 hr at 4°C. (E) The experiments described in D were 
repeated except that Cyto-A was replaced with 200 µM LatA (H+L).  




 In this section, the effect of LatA and other actin-interacting drugs on the 
activation of the cAMP signaling pathway were investigated in strains expressing 
versions of Cap1 lacking the G-actin-binding domain. First, the mRNA levels of 
HSGs during hyphal induction in the presence or absence of LatA was examined. In 
wild type cells, adding LatA to the induction medium reduced the levels of HSG 
activation to 2-8% of the normal induction level, whereas adding db-cAMP together 
with LatA restored the activation to 15-35% of the normal level, suggesting that LatA 
has an effect on cAMP signaling. Later, I provide evidence that the effect of LatA is 
mediated through its interaction with the G-actin in the Cyr1/Cap1/G-actin complex. 
First, I found that in the strain that expresses Cap1-C26Δ lacking the G-actin-binding 
site, the effect of LatA was significantly weakened. Second, in the strain CCC, in 
which the C-terminal half of Cap1 is fused directly with the C-terminal end of Cyr1 as 
the only source of both Cyr1 and Cap1, LatA exhibited the same inhibitory effect on 
HGS expression as in wild-type cells. Third, LatA and Cyto-A were found to reduce 
cAMP production induced by serum in the cyclase activity assays of wild-type cell 
lysates, while they had no effect in the cell lysates containing Cap1 mutants lacking 
its C-terminal 26 amino acids. Together, the data indicate that the G-actin-binding 
motif at the C-terminal end of Cap1 plays an important role in mediating the effect of 
the actin toxins on cAMP production. Next, I performed adenylyl cyclase activity 
assays using the purified Cyr1/Cap1/G-actin complex. Because in this simplified 
system, non-specific interferences from other cellular components are minimized, any 
observed effects of the actin toxins on Cyr1 acrtivity would be most likely due to their 
binding to the G-actin in the complex. I found that this protein complex is not only 
active in cAMP synthesis but also capable of increasing cAMP production in response 
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to serum. Furthermore, the activation of cAMP production in this system was also 
blocked by LatA and Cyto-A. In comparison, the complex purified from cells 
expressing Cyr1-HFM and Cap1-C26Δ was insensitive to LatA and Cyto-A 
treatments. Taken together, the results provide compelling evidence that G-actin plays 
a direct role in activating cAMP production by Cyr1 and this activation requires Cap1. 
Since neither LatA nor Cyto-A causes G-actin dissociation from Cap1, it is most 
likely that binding of the drugs to G-actin causes a conformational change in the 
Cyr1/Cap1/G-actin complex that impairs its normal function. 




5.1 G-actin plays an important role in regulating Cyr1 activity 
through Cap1 
In C. albicans, Cap1 is essential for hyphal growth. Previous studies in S. 
cerevisiae (Hubberstey and Mottillo, 2002) and C. albcians (Bahn and Sundstrom, 
2001) and my earlier experiments in this project suggest that Cap1 has dual functions 
as a regulator of both the adenylyl cyclase Cyr1 and the actin cytoskeleton. My results 
showed that Cap1 is required for Cyr1 to increase cAMP synthesis in response to 
hyphal induction and for the normal distribution of cortical actin patches. Since Cap1 
has the capacity to bind to adenylyl cyclase or actin in S. cerevisiae, it prompted us to 
ask whether Cap1 might be able to bind simultaneously both Cyr1 and actin, thereby 
providing a platform for crosstalk between the cAMP/PKA cascade and the cellular 
status of the actin cytoskeleton for proper control of the C. albicans hyphal 
development.  
To address this hypothesis, I first performed a series of co-
immunoprecipitation experiments to confirm that Cap1 can indeed simultaneously 
bind both Cyr1 and actin, acting as a bridge in the Cyr1/Cap1/actin complex. I also 
defined two regions of Cap1 important for interacting with Cyr1 and actin: the N 
terminus is responsible for binding Cyr1 and the C terminus for binding G-actin. My 
results also indicate that the form of actin in the ternary complex is G-actin instead of 
F-actin.  
To determine whether G-actin has a role in regulating Cyr1 activity, I 
compared cellular cAMP levels during hyphal induction in wild-type cells and mutant 
cells expressing a version of Cap1 lacking the C-terminal G-actin binding site (strain 
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CAP-C26Δ). In CAP-C26Δ cells the peak of cellular cAMP in response to hyphal 
induction is both significantly lower and delayed than in wild-type cells, suggesting a 
role for G-actin in activating Cyr1. Consistently, CAP-C26Δ cells exhibited defects in 
hyphal morphology, which is particularly obvious under weaker hyphal-inducing 
conditions such as media containing lower concentrations of serum.      
G-actin may influence Cyr1’s activity by two possible non-mutually exclusive 
mechanisms. First, G-actin binding at the C-terminus of Cap1 may be important for 
Cap1 to assume a conformation for optimal interaction of its N-terminal end with 
Cyr1. Second, G-actin may activate cAMP synthesis by making direct contact with 
Cyr1, and binding to the C terminal end of Cap1 is necessary for this interaction. To 
distinguish between these two possibilities, I engineered a construct (Cyr1-Cap1-C) in 
which the C-terminal half of Cap1 is joined with the C-terminal end of Cyr1 and 
expressed it in the cap1Δ/cap1Δ mutant (strain CCC). This strain eliminated the 
influence of the N-terminal end of Cap1 on Cyr1 activation, but retained the G-actin 
binding site at the C terminal end of Cap1. This strain exhibited significant hyphal 
growth in contrast to the complete lack of it in the parental strain. The CCC strain was 
also capable of generating a cAMP peak in response to hyphal induction. While the 
peak was lower and delayed in comparison with wild type, it was similar to that 
observed in the mutant expressing the Cap1 N terminal half. However, when the C 
terminal 26 amino acids were deleted from the Cyr1-Cap1-C construct, the strain 
completely lost its ability of producing the post-induction cAMP spike and that of 
hyphal growth. Thus the results are consistent with the idea that G-actin plays a direct 
role in activating Cyr1, which is independent of the N terminus of Cap1 but requires 
the C terminus probably to bring it in close contact with Cyr1. Taken together my 
results indicate that both ends of Cap1 contribute to Cyr1 activation to ensure optimal 
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cellular response to hyphal induction. Thus, I propose that Cap1 activates Cyr1 during 
hyphal induction by two distinct separable mechanisms. One is mediated by its N 
terminus which is classically known to interact with and activate Cyr1, and the other 
is achieved through its C terminus by recruiting G-actin to enhance the activity of 
Cyr1. 
The role of Cap1 in bridging actin and Cyr1 has been implicated in S. 
cerevisiae too. Gourlay and Ayscough (2006) reported that Srv2 (Cap1) was required 
for Ras signaling activated by actin aggregation in end3Δ cells. They found that both 
the N and the C terminus were important for the activation, while the central proline-
rich domains, which determine Cap1’s association with F-actin, were not required. 
They also found that treating end3Δ cells with LatA prevented the activation of the 
Ras/cAMP signaling pathway. Thus, in S. cerevisiae, destabilization of F-actin also 
suppresses cAMP signaling in a Cap1 (Srv2)-dependent manner, consistent with my 
findings in this study. Actin cytoskeleton status feeding back to signaling pathways 
(Head et al., 2006; Pelkmans et al., 2002; Stahlhut and van Deurs, 2000) have also 
been reported in other systems, suggesting a common phenomenon. 
  
5.2 Repression of  the cAMP pathway by actin depolymerizing toxins  
Hazan and Liu (2002) reported that LatA impaired the transcriptional 
induction of hypha-specific genes HWP1, ECE1 and HYR1. Later, Wolyniak and 
Sundstrom (2007) reported that not only LatA, other F-actin destabilizing reagents 
such as Cyto-A also repressed the expression of HWP1, while the F-actin stabilizing 
compound jasplakinolide had no effect. Besides F-actin destabilizing drugs, actin-
compromised mutant strains such as bni1/bni1 and cdc42E100G also showed decreased 
induction of HWP1. These reports suggest the requirement of proper actin status for 
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efficient induction of HSG expression. In this study, since I had noticed that G-actin 
contributes to the regulation of the cAMP pathway, I further investigated whether the 
effects of the actin depolymerizing toxins on HSG expression is a result of Cyr1 
activity suppression. 
To address this, I first assessed the effect of LatA on the level of HSGs in the 
presence or absence of a membrane-permeable cAMP derivative. I found that adding 
cAMP together with LatA partially alleviated the inhibitory effect of LatA on HSG 
expression, suggesting that LatA exerts its effect most likely by reducing the cAMP 
level. Moreover, I found that HSG expression was largely unaffected by LatA in the 
Cap1-C26Δ mutant, suggesting that the C-terminal end of Cap1 that contains G-actin 
binding sites has an important role in mediating the effect of LatA. Consistent with 
this idea, strain CCC that expresses the Cap1 C-terminal half fused to the C-terminal 
end of Cyr1 exhibited reduced HSG expression in the presence of LatA, whereas 
deleting the C-terminal 26 amino acids from this fusion protein rendered the cell LatA 
resistant. In contrast, the strains expressing Cap1 mutants deleted of the proline-rich 
domains P1 or P2, which are thought to be involved in F-actin binding, are unaffected 
in LatA sensitivity. Taken together, my data strongly support the idea that G-actin 
may play an important role in regulating the cAMP pathway through interacting with 
the C-terminal end of Cap1.  
To determine whether the drug treatment inhibits the adenylyl cyclase activity 
of Cyr1, I measured the synthesis of cAMP in cell lysates in the presence or absence 
of LatA or Cyto-A. I found that both drugs markedly inhibited cAMP synthesis in a 
concentration-dependent manner in the wild-type cell lysates. In striking contrast, 
they had little effect in the CAP-C26Δ lysates. The results are consistent with the 
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hypothesis that the actin toxins inhibit the cyclase activity in a manner dependent on 
G-actin binding to the Cap1 C terminus. 
How do the actin depolymerizing drugs inhibit cAMP synthesis? One 
possibility is that binding of the drugs to G-actin may cause its dissociation from the 
Cyr1/Cap1/G-actin complex. But this possibility was ruled out by the finding that 
LatA and Cyto-C treatment of cell lysates did not reduce the level of coprecipitation 
of actin with Cap1. The an alternative explanation is that LatA or Cyto-A binding to 
G-actin may cause a conformational change of the Cyr1/Cap1/actin complex that 
impairs the activation of the cyclase activity in response to hyphal induction. 
Structural studies of LatA and Cyto-A interaction with actin have been conducted in 
many laboratories, indicating significant conformational changes of actin. LatA is a 
compound isolated from the Red Sea sponge Negombata magnifica. Structures of 
LatA and the LatA-actin complex have been elucidated by crystallography (Morton et 
al., 2000). Its actin binding site is located close to the nucleotide binding cleft of actin. 
The tyrosine 69 in subdomain 2 and threonine 186 and arginine 210 in subdomain 4 
of actin form hydrogen bonds with the drug (Yarmola et al., 2000). LatA binding 
causes a structural change that inhibits the nucleotide exchange of actin which 
precludes its participation in polymerization. Cyto-A belongs to cytochalasins, a 
group of fungal metabolites, which bind to the barbed end of actin filaments inhibiting 
both the association and dissociation of subunits at that end. The stoichometry of 
cytochalasin and G-actin interaction is 1:1. Cytochalasin binds rapidly and loosely to 
an actin monomer, followed by a conformational change of the complex to a state 
where the cytochalasin is bound more tightly. The binding accelerates the 
dimerization of actin while prohibits the polymerization (Cooper, 1987). Besides 
these common properties of cytochalasins, Cyto-A is a sulfhydryl-reactive agent. Its 
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effects can be abolished by cysteine or dithiothreitol (Kuo and Lampen, 1975; 
Wolyniak and Sundstrom, 2007). The cysteine 272 of actin in the crystallized actin 
dimmer is likely to be a cysteine sulfinic acid (Lassing et al., 2007), thus Cyto-A may 
have the ability to alter the confirmation of actin dimers. Thus, I propose that the 
specific conformation of the LatA-actin and Cyto-A-actin complexes may alter the 
whole conformation of Cyr1/Cap1/actin complex, partially preventing the activation 
of the adenylyl cyclase during hyphal induction. However, structural studies are 
necessary to test this hypothesis.  
 
5.3 Capacity of the Cyr1-Cap1-actin ternary complex 
In this study, I have affinity-purified a protein complex containing Cyr1, Cap1 
and actin. By using a series of Cap 1 mutants deleted of different domains, I 
established that in the ternary complex Cap1 acts as a bridge that links Cyr1 and G-
actin. Such a complex provides a structural platform for the regulation of Cyr1 
activity by G-actin.  
Moreover, this complex retains the ability to respond to hyphal induction. I 
found that adding serum to the purified complex in test tubes, cAMP synthesis was 
greatly enhanced with a kinetics similar to that observed by using cell lysates, 
indicating that the complex is essentially an intact sensor/effector module for the 
hyphal-induced increase of cAMP production. Recent studies by our laboratory (Xu et 
al., 2008) provide strong evidence that the leucine-rich repeat (LRR) domain of Cyr1 
may play the sensory role. LRR domains are present in many cell surface and 
cytoplasmic proteins responsible for sensing invading infectious agents in diverse 
organisms (DeYoung and Innes, 2006; Kufer, 2008).  
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The purified Cyr1/Cap1/actin complex will be very useful for further detailed 
studies of ligand–receptor interactions and the mechanisms underlying the activation 
of Cyr1. This simple system would allow better definition of roles association with 
each component in the complex without the influence of other undefined cellular 
components. 
  
5.4 Significance of the cAMP spike during hyphal induction  
The key role of the cAMP signaling pathway in the hyphal growth of C. 
albicans has been well established. Blocking this pathway affects hyphal growth in a 
wide range of induction conditions (Chapter 1.3.1). Rapid activation of cAMP 
synthesis is an important step for the activation of this pathway. Normally, in 
response to hyphal induction, the intracellular cAMP level increases sharply and 
reaches the peak level at ~30min, after which it decreases gradually over an extended 
period. The cellular cAMP generator is Cyr1/Cap1/actin complex. However, I found 
that adding external cAMP into cap1Δ/Δ cells cannot restore hyphal growth unless 
they are under hyphal induction conditions. There may be two possible explanations 
for this phenomenon. First, the cAMP spike might be more important than the 
absolute level of cAMP, and second the increase of cAMP levels is essential but not 
sufficient for hyphal growth. Consistent with the first explanation, a mutant deleted of 
the high-affinity cAMP phosphodiesterase gene PDE2 exhibited increased cellular 
cAMP levels compared to wild type without filamentous growth under non-inducing 
conditions (Bahn, et al., 2003). This also helps explain why external cAMP could 
only partially rescue HSG expression in cap1Δ/Δ cells in my experiment. However, C. 
albicans cells also produce similar intracellular cAMP spikes when shifted to certain 
nutrition-starvation and stress conditions without hyphal growth (Jain et al., 2003). 
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Thus, other cAMP-independent cellular processes important for hyphal growth should 
also exist. 
One of the cAMP-independent cellular processes important for hyphal 
formation is the phosphorylation of the septin Cdc11. Sinha and the co-authors (2007) 
found that as early as 5 min after induction, Cdc11 becomes phosphorylated by 
Cdc28-Ccn1, well before the expression of HSGs; and in fact the phosphorylation can 
happen normally in cells deleted of the transcription factors responsible for HSG 
expression, suggesting that this phosphorylation may not be regulated by cAMP 
pathway. Since septin complexes are important for the establishment of actin polarity, 
it suggests that the early stage of actin polarity may also be independent of the cAMP 
signaling pathway. Later on, the authors reported that the maintenance of the 
phosphorylation of Cdc11 thorughout hyphal growth requires Cdc28-Hgc1. Since 
Hgc1 is a downstream effecter of the cAMP pathway, it indicates that only after the 
early stage of actin polarization, the septin phosphorylation and consequently actin 
polarity are controlled by cAMP.  
 
5.5 Conclusion 
Main discoveries made in this study 
z I performed functional characterization of the C. albicans cyclase-associated 
protein Cap1 and confirmed its roles in regulating Cyr1 activity and the actin 
cytoskeleton, including (i) association with and activation of Cyr1 through its 
N terminus, (ii) interaction with F-actin through its P2 region and the role of 
this interaction in maintaining normal patterns of cortical actin patches, (iii) 
involvement in the internalization step of endocytosis, and (iv) direct 
interaction with ADP-G-actin through its C terminus. 
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z I identified the Cyr1/Cap1/actin ternary complex, which has the capacity in 
sensing the hyphal-inducing signals and increase cAMP synthesis. I 
established that Cap1 acts as a bridge linking Cyr1 and G-actin in the ternary 
complex, providing a structural platform for G-actin to regulate the adenylyl 
cyclase activity of Cyr1 through binding to the C terminus of Cap1.  
z I investigated the mechanisms by which the actin depolymerizing toxins LatA 
and Cyto-C inhibit the Cyr1 activity. I propose that the toxins bind to the G-
actin component of the complex, resulting in a conformation that responds 
poorly to hyphal-inducing reagents. 
  
Main contributions of this study 
z The discovery of the role of G-actin and Cap1 in regulating the adenylyl 
cyclase activity links two important cellular processes in hyphal growth: the 
cAMP signaling pathway and the status of the actin cytoskeleton. 
z The discovery of the actin depolymerizing toxins suppressing cAMP synthesis 
reveals the mechanism by which these toxins inhibit the expression of HSGs 
during hyphal induction. 
z The discovery that the purified Cyr1/Cap1/actin complex is sufficient for 
sensing the hyphal-inducing signals in serum and increasing cAMP synthesis 
indicates that the complex is essentially an intact sensor/effector module. This 
represents a ground breaking discovery in understanding how C. albicans 
responds to the host blood in establishing infections in humans. 
  
Future plan 
z Structural studies of conformational changes of the Cyr1/Cap1/actin complex 
caused by the actin depolymerizing toxins. 
Chapter5  Discussion 
 108
z Using purified Cyr1/Cap1/actin complexes to study the roles of each 
component in signal sensing and activation of the Cyr1 activity.  
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